2401
|
Chow FY, Nikolic-Paterson DJ, Ma FY, Ozols E, Rollins BJ, Tesch GH. Monocyte chemoattractant protein-1-induced tissue inflammation is critical for the development of renal injury but not type 2 diabetes in obese db/db mice. Diabetologia 2007; 50:471-80. [PMID: 17160673 DOI: 10.1007/s00125-006-0497-8] [Citation(s) in RCA: 190] [Impact Index Per Article: 11.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/06/2006] [Accepted: 09/05/2006] [Indexed: 01/12/2023]
Abstract
AIMS/HYPOTHESIS Tissue macrophage accumulation is thought to induce insulin resistance during obesity and stimulate the progression of diabetic nephropathy. Monocyte chemoattractant protein-1 (MCP-1) is a potent stimulator of macrophage recruitment. It is increased in adipose tissue during obesity and in diabetic kidneys, suggesting that inflammation of these tissues may be MCP-1-dependent. Based on these findings, the aim of this study was to examine whether a deficiency in MCP-1 would alter the development of type 2 diabetes and its renal complications. MATERIALS AND METHODS The role of MCP-1 in the progression of type 2 diabetes and its associated renal injury was assessed in obese db/db mice that were deficient in the gene encoding MCP-1 (Ccl2). RESULTS The incidence and development of type 2 diabetes were similar in Ccl2(+/+) and Ccl2(-/-) db/db mice between 8 and 32 weeks of age. Body mass, hyperglycaemia, hyperinsulinaemia, glucose and insulin tolerance, plasma triacylglycerol and serum NEFA were not different between these strains. Pathological changes in epididymal adipose tissue, including increases in macrophage accumulation and Tnfa mRNA and reductions in Adipoq mRNA, were unaffected by the absence of MCP-1. In contrast, kidney macrophage accumulation and the progression of diabetic renal injury (albuminuria, histopathology, renal fibrosis) were substantially reduced in Ccl2(-/-) compared with Ccl2(+/+) db/db mice with equivalent diabetes. CONCLUSIONS/INTERPRETATION Our study demonstrates that MCP-1 promotes type 2 diabetic renal injury but does not influence the development of obesity, insulin resistance or type 2 diabetes in db/db mice. MCP-1 plays a critical role in inflammation of the kidney, but not adipose tissue, during the progression of type 2 diabetes.
Collapse
Affiliation(s)
- F Y Chow
- Department of Nephrology, Monash Medical Centre, Clayton, VIC, 3168, Australia
| | | | | | | | | | | |
Collapse
|
2402
|
Katiyar SK, Meeran SM. Obesity increases the risk of UV radiation-induced oxidative stress and activation of MAPK and NF-kappaB signaling. Free Radic Biol Med 2007; 42:299-310. [PMID: 17189835 PMCID: PMC1805635 DOI: 10.1016/j.freeradbiomed.2006.10.049] [Citation(s) in RCA: 62] [Impact Index Per Article: 3.6] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/22/2006] [Revised: 10/17/2006] [Accepted: 10/25/2006] [Indexed: 10/24/2022]
Abstract
Obesity has been implicated in several diseases, including cancer; however, the relationship of obesity and susceptibility to ultraviolet (UV) radiation-caused skin diseases has not been investigated. As UV-induced oxidative stress has been implicated in several skin diseases, we assessed the role of obesity on UVB-induced oxidative stress in genetically obese Lep(ob)/Lep(ob) (leptin-deficient) mice. Here, we report that chronic exposure to UVB (120 mJ/cm(2)) resulted in greater oxidative stress in the skin of obese mice in terms of higher levels of H(2)O(2) and NO production, photo-oxidative damage of lipids and proteins, and greater depletion of antioxidant defense enzymes, like glutathione, glutathione peroxidase, and catalase. As UV-induced oxidative stress mediates activation of MAPK and NF-kappaB signaling pathways, we determined the effects of UVB on these pathways in obese mice. Exposure of obese mice to UVB resulted in phosphorylation of ERK1/2, JNK, and p38 proteins of the MAPK family. Compared to wild-type mice, the obese mice exhibited higher levels of phosphorylation of these proteins, greater activation of NF-kappaB/p65, and higher levels of circulating proinflammatory cytokines, including TNF-alpha, IL-1beta and IL-6, on UVB irradiation. Taking these results together, our study suggests for the first time that obesity in mice is associated with greater susceptibility to UVB-induced oxidative stress and therefore may be a risk factor for skin diseases associated with UVB-induced oxidative stress.
Collapse
Affiliation(s)
- Santosh K Katiyar
- Department of Dermatology, University of Alabama at Birmingham, P.O. Box 202, Volker Hall 557, 1670 University Boulevard, Birmingham, AL 35294, USA.
| | | |
Collapse
|
2403
|
Abstract
Adipocytes have been studied with increasing intensity as a result of the emergence of obesity as a serious public health problem and the realization that adipose tissue serves as an integrator of various physiological pathways. In particular, their role in calorie storage makes adipocytes well suited to the regulation of energy balance. Adipose tissue also serves as a crucial integrator of glucose homeostasis. Knowledge of adipocyte biology is therefore crucial for understanding the pathophysiological basis of obesity and metabolic diseases such as type 2 diabetes. Furthermore, the rational manipulation of adipose physiology is a promising avenue for therapy of these conditions.
Collapse
Affiliation(s)
- Evan D Rosen
- Division of Endocrinology and Metabolism, Beth Israel Deaconess Medical Centre, 330 Brookline Avenue, Boston, Massachusetts 02215, USA
| | | |
Collapse
|
2404
|
Jager J, Grémeaux T, Cormont M, Le Marchand-Brustel Y, Tanti JF. Interleukin-1beta-induced insulin resistance in adipocytes through down-regulation of insulin receptor substrate-1 expression. Endocrinology 2007; 148:241-51. [PMID: 17038556 PMCID: PMC1971114 DOI: 10.1210/en.2006-0692] [Citation(s) in RCA: 498] [Impact Index Per Article: 29.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/14/2022]
Abstract
Inflammation is associated with obesity and insulin resistance. Proinflammatory cytokines produced by adipose tissue in obesity could alter insulin signaling and action. Recent studies have shown a relationship between IL-1beta level and metabolic syndrome or type 2 diabetes. However, the ability of IL-1beta to alter insulin signaling and action remains to be explored. We demonstrated that IL-1beta slightly increased Glut 1 translocation and basal glucose uptake in 3T3-L1 adipocytes. Importantly, we found that prolonged IL-1beta treatment reduced the insulin-induced glucose uptake, whereas an acute treatment had no effect. Chronic treatment with IL-1beta slightly decreased the expression of Glut 4 and markedly inhibited its translocation to the plasma membrane in response to insulin. This inhibitory effect was due to a decrease in the amount of insulin receptor substrate (IRS)-1 but not IRS-2 expression in both 3T3-L1 and human adipocytes. The decrease in IRS-1 amount resulted in a reduction in its tyrosine phosphorylation and the alteration of insulin-induced protein kinase B activation and AS160 phosphorylation. Pharmacological inhibition of ERK totally inhibited IL-1beta-induced down-regulation of IRS-1 mRNA. Moreover, IRS-1 protein expression and insulin-induced protein kinase B activation, AS160 phosphorylation, and Glut 4 translocation were partially recovered after treatment with the ERK inhibitor. These results demonstrate that IL-1beta reduces IRS-1 expression at a transcriptional level through a mechanism that is ERK dependent and at a posttranscriptional level independently of ERK activation. By targeting IRS-1, IL-1beta is capable of impairing insulin signaling and action, and could thus participate in concert with other cytokines, in the development of insulin resistance in adipocytes.
Collapse
|
2405
|
Lumeng CN, Deyoung SM, Saltiel AR. Macrophages block insulin action in adipocytes by altering expression of signaling and glucose transport proteins. Am J Physiol Endocrinol Metab 2007; 292:E166-74. [PMID: 16926380 PMCID: PMC3888778 DOI: 10.1152/ajpendo.00284.2006] [Citation(s) in RCA: 250] [Impact Index Per Article: 14.7] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/06/2023]
Abstract
Obesity leads to a proinflammatory state with immune responses that include infiltration of adipose tissue with macrophages. These macrophages are believed to alter insulin sensitivity in adipocytes, but the mechanisms that underlie this effect have not been characterized. We have explored the interaction between macrophages and adipocytes in the context of both indirect and direct coculture. Macrophage-secreted factors blocked insulin action in adipocytes via downregulation of GLUT4 and IRS-1, leading to a decrease in Akt phosphorylation and impaired insulin-stimulated GLUT4 translocation to the plasma membrane. GLUT1 was upregulated with a concomitant increase in basal glucose uptake. These changes recapitulate those seen in adipose tissue from insulin-resistant humans and animal models. TNF-alpha-neutralizing antibodies partially reversed the insulin resistance produced by macrophage-conditioned media. Peritoneal macrophages and macrophage-enriched stromal vascular cells from adipose tissue also attenuated responsiveness to insulin in a manner correlating with inflammatory cytokine secretion. Adipose tissue macrophages from obese mice have an F4/80(+)CD11b(+)CD68(+)CD14(-) phenotype and form long cellular extensions in culture. Peritoneal macrophages take on similar characteristics in direct coculture with adipocytes and induce proinflammatory cytokines, suggesting that macrophage activation state is influenced by contact with adipocytes. Thus both indirect/secreted and direct/cell contact-mediated factors derived from macrophages influence insulin sensitivity in adipocytes.
Collapse
Affiliation(s)
- Carey N Lumeng
- Life Sciences Institute, 210 Washtenaw Ave., Ann Arbor, MI 48109, USA
| | | | | |
Collapse
|
2406
|
Desruisseaux MS, Trujillo ME, Tanowitz HB, Scherer PE. Adipocyte, adipose tissue, and infectious disease. Infect Immun 2006; 75:1066-78. [PMID: 17118983 PMCID: PMC1828569 DOI: 10.1128/iai.01455-06] [Citation(s) in RCA: 110] [Impact Index Per Article: 6.1] [Reference Citation Analysis] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/18/2022] Open
Affiliation(s)
- Mahalia S Desruisseaux
- Department of Pathology, Albert Einstein College of Medicine, 1300 Morris Park Ave., Bronx, NY 10461, USA
| | | | | | | |
Collapse
|
2407
|
Cereda E, Malavazos AE. Comment on: White PJ, Marette A (2006) is omega-3 key to unlocking inflammation in obesity? Diabetologia 49:1999-2001. Diabetologia 2006; 49:2813-4. [PMID: 17047915 DOI: 10.1007/s00125-006-0453-7] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 08/08/2006] [Accepted: 08/14/2006] [Indexed: 10/24/2022]
|
2408
|
Shi H, Kokoeva MV, Inouye K, Tzameli I, Yin H, Flier JS. TLR4 links innate immunity and fatty acid-induced insulin resistance. J Clin Invest 2006; 116:3015-25. [PMID: 17053832 PMCID: PMC1616196 DOI: 10.1172/jci28898] [Citation(s) in RCA: 2656] [Impact Index Per Article: 147.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/24/2006] [Accepted: 09/12/2006] [Indexed: 02/06/2023] Open
Abstract
TLR4 is the receptor for LPS and plays a critical role in innate immunity. Stimulation of TLR4 activates proinflammatory pathways and induces cytokine expression in a variety of cell types. Inflammatory pathways are activated in tissues of obese animals and humans and play an important role in obesity-associated insulin resistance. Here we show that nutritional fatty acids, whose circulating levels are often increased in obesity, activate TLR4 signaling in adipocytes and macrophages and that the capacity of fatty acids to induce inflammatory signaling in adipose cells or tissue and macrophages is blunted in the absence of TLR4. Moreover, mice lacking TLR4 are substantially protected from the ability of systemic lipid infusion to (a) suppress insulin signaling in muscle and (b) reduce insulin-mediated changes in systemic glucose metabolism. Finally, female C57BL/6 mice lacking TLR4 have increased obesity but are partially protected against high fat diet-induced insulin resistance, possibly due to reduced inflammatory gene expression in liver and fat. Taken together, these data suggest that TLR4 is a molecular link among nutrition, lipids, and inflammation and that the innate immune system participates in the regulation of energy balance and insulin resistance in response to changes in the nutritional environment.
Collapse
Affiliation(s)
- Hang Shi
- Division of Endocrinology, Department of Medicine, Beth Israel Deaconess Medical Center, and Harvard Medical School, Boston, Massachusetts 02215, USA
| | | | | | | | | | | |
Collapse
|
2409
|
Abstract
It is now well accepted that diabetes mellitus is one of the main threats to human health in the twenty-first century. The total number of people with diabetes worldwide was estimated at between 151 million and 171 million in 2000 and is projected to increase to 221 million in 2010 and to 366 million in 2030. Needless to say, the increase in the number of people with diabetes will be accompanied by an increase in the number of those with diabetic complications such as nephropathy, retinopathy, neuropathy, and atherosclerosis. The global mortality attributable to diabetes in the year 2000 was estimated at 2.9 million deaths, a number that will also increase. Given that type 2 diabetes accounts for more than 90% of cases of diabetes worldwide, it is important that we understand the pathogenesis of this condition and develop new approaches to its prevention and treatment.
Collapse
Affiliation(s)
- Masato Kasuga
- Department of Clinical Molecular Medicine, Kobe University Graduate School of Medicine, Kobe, Japan.
| |
Collapse
|
2410
|
Valerio A, Cardile A, Cozzi V, Bracale R, Tedesco L, Pisconti A, Palomba L, Cantoni O, Clementi E, Moncada S, Carruba MO, Nisoli E. TNF-alpha downregulates eNOS expression and mitochondrial biogenesis in fat and muscle of obese rodents. J Clin Invest 2006; 116:2791-8. [PMID: 16981010 PMCID: PMC1564431 DOI: 10.1172/jci28570] [Citation(s) in RCA: 241] [Impact Index Per Article: 13.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/20/2006] [Accepted: 07/25/2006] [Indexed: 12/16/2022] Open
Abstract
Obesity is associated with chronic low-grade inflammation. Thus, at metabolically relevant sites, including adipose tissue and muscle, there is abnormal production of proinflammatory cytokines such as TNF-alpha. Here we demonstrate that eNOS expression was reduced, with a concomitant reduction of mitochondrial biogenesis and function, in white and brown adipose tissue and in the soleus muscle of 3 different animal models of obesity. The genetic deletion of TNF receptor 1 in obese mice restored eNOS expression and mitochondrial biogenesis in fat and muscle; this was associated with less body weight gain than in obese wild-type controls. Furthermore, TNF-alpha downregulated eNOS expression and mitochondrial biogenesis in cultured white and brown adipocytes and muscle satellite cells of mice. The NO donors DETA-NO and SNAP prevented the reduction of mitochondrial biogenesis observed with TNF-alpha. Our findings demonstrate that TNF-alpha impairs mitochondrial biogenesis and function in different tissues of obese rodents by downregulating eNOS expression and suggest a novel pathophysiological process that sustains obesity.
Collapse
Affiliation(s)
- Alessandra Valerio
- Integrated Laboratories Network, Center for Study and Research on Obesity, Department of Pharmacology, School of Medicine, University of Milan, Milan, Italy.
Department of Preclinical Sciences, University of Milan, Milan, Italy.
CEINGE Biotecnologie Avanzate, Naples, Italy.
Istituto Auxologico Italiano, Milan, Italy.
Stem Cell Research Institute, San Raffaele Scientific Institute, Milan, Italy.
Istituto di Farmacologia e Farmacognosia, University of Urbino “Carlo Bo,” Urbino, Italy.
Eugenio Medea Scientific Institute, Lecco, Italy.
Wolfson Institute for Biomedical Research, University College London, London, United Kingdom
| | - Annalisa Cardile
- Integrated Laboratories Network, Center for Study and Research on Obesity, Department of Pharmacology, School of Medicine, University of Milan, Milan, Italy.
Department of Preclinical Sciences, University of Milan, Milan, Italy.
CEINGE Biotecnologie Avanzate, Naples, Italy.
Istituto Auxologico Italiano, Milan, Italy.
Stem Cell Research Institute, San Raffaele Scientific Institute, Milan, Italy.
Istituto di Farmacologia e Farmacognosia, University of Urbino “Carlo Bo,” Urbino, Italy.
Eugenio Medea Scientific Institute, Lecco, Italy.
Wolfson Institute for Biomedical Research, University College London, London, United Kingdom
| | - Valeria Cozzi
- Integrated Laboratories Network, Center for Study and Research on Obesity, Department of Pharmacology, School of Medicine, University of Milan, Milan, Italy.
Department of Preclinical Sciences, University of Milan, Milan, Italy.
CEINGE Biotecnologie Avanzate, Naples, Italy.
Istituto Auxologico Italiano, Milan, Italy.
Stem Cell Research Institute, San Raffaele Scientific Institute, Milan, Italy.
Istituto di Farmacologia e Farmacognosia, University of Urbino “Carlo Bo,” Urbino, Italy.
Eugenio Medea Scientific Institute, Lecco, Italy.
Wolfson Institute for Biomedical Research, University College London, London, United Kingdom
| | - Renata Bracale
- Integrated Laboratories Network, Center for Study and Research on Obesity, Department of Pharmacology, School of Medicine, University of Milan, Milan, Italy.
Department of Preclinical Sciences, University of Milan, Milan, Italy.
CEINGE Biotecnologie Avanzate, Naples, Italy.
Istituto Auxologico Italiano, Milan, Italy.
Stem Cell Research Institute, San Raffaele Scientific Institute, Milan, Italy.
Istituto di Farmacologia e Farmacognosia, University of Urbino “Carlo Bo,” Urbino, Italy.
Eugenio Medea Scientific Institute, Lecco, Italy.
Wolfson Institute for Biomedical Research, University College London, London, United Kingdom
| | - Laura Tedesco
- Integrated Laboratories Network, Center for Study and Research on Obesity, Department of Pharmacology, School of Medicine, University of Milan, Milan, Italy.
Department of Preclinical Sciences, University of Milan, Milan, Italy.
CEINGE Biotecnologie Avanzate, Naples, Italy.
Istituto Auxologico Italiano, Milan, Italy.
Stem Cell Research Institute, San Raffaele Scientific Institute, Milan, Italy.
Istituto di Farmacologia e Farmacognosia, University of Urbino “Carlo Bo,” Urbino, Italy.
Eugenio Medea Scientific Institute, Lecco, Italy.
Wolfson Institute for Biomedical Research, University College London, London, United Kingdom
| | - Addolorata Pisconti
- Integrated Laboratories Network, Center for Study and Research on Obesity, Department of Pharmacology, School of Medicine, University of Milan, Milan, Italy.
Department of Preclinical Sciences, University of Milan, Milan, Italy.
CEINGE Biotecnologie Avanzate, Naples, Italy.
Istituto Auxologico Italiano, Milan, Italy.
Stem Cell Research Institute, San Raffaele Scientific Institute, Milan, Italy.
Istituto di Farmacologia e Farmacognosia, University of Urbino “Carlo Bo,” Urbino, Italy.
Eugenio Medea Scientific Institute, Lecco, Italy.
Wolfson Institute for Biomedical Research, University College London, London, United Kingdom
| | - Letizia Palomba
- Integrated Laboratories Network, Center for Study and Research on Obesity, Department of Pharmacology, School of Medicine, University of Milan, Milan, Italy.
Department of Preclinical Sciences, University of Milan, Milan, Italy.
CEINGE Biotecnologie Avanzate, Naples, Italy.
Istituto Auxologico Italiano, Milan, Italy.
Stem Cell Research Institute, San Raffaele Scientific Institute, Milan, Italy.
Istituto di Farmacologia e Farmacognosia, University of Urbino “Carlo Bo,” Urbino, Italy.
Eugenio Medea Scientific Institute, Lecco, Italy.
Wolfson Institute for Biomedical Research, University College London, London, United Kingdom
| | - Orazio Cantoni
- Integrated Laboratories Network, Center for Study and Research on Obesity, Department of Pharmacology, School of Medicine, University of Milan, Milan, Italy.
Department of Preclinical Sciences, University of Milan, Milan, Italy.
CEINGE Biotecnologie Avanzate, Naples, Italy.
Istituto Auxologico Italiano, Milan, Italy.
Stem Cell Research Institute, San Raffaele Scientific Institute, Milan, Italy.
Istituto di Farmacologia e Farmacognosia, University of Urbino “Carlo Bo,” Urbino, Italy.
Eugenio Medea Scientific Institute, Lecco, Italy.
Wolfson Institute for Biomedical Research, University College London, London, United Kingdom
| | - Emilio Clementi
- Integrated Laboratories Network, Center for Study and Research on Obesity, Department of Pharmacology, School of Medicine, University of Milan, Milan, Italy.
Department of Preclinical Sciences, University of Milan, Milan, Italy.
CEINGE Biotecnologie Avanzate, Naples, Italy.
Istituto Auxologico Italiano, Milan, Italy.
Stem Cell Research Institute, San Raffaele Scientific Institute, Milan, Italy.
Istituto di Farmacologia e Farmacognosia, University of Urbino “Carlo Bo,” Urbino, Italy.
Eugenio Medea Scientific Institute, Lecco, Italy.
Wolfson Institute for Biomedical Research, University College London, London, United Kingdom
| | - Salvador Moncada
- Integrated Laboratories Network, Center for Study and Research on Obesity, Department of Pharmacology, School of Medicine, University of Milan, Milan, Italy.
Department of Preclinical Sciences, University of Milan, Milan, Italy.
CEINGE Biotecnologie Avanzate, Naples, Italy.
Istituto Auxologico Italiano, Milan, Italy.
Stem Cell Research Institute, San Raffaele Scientific Institute, Milan, Italy.
Istituto di Farmacologia e Farmacognosia, University of Urbino “Carlo Bo,” Urbino, Italy.
Eugenio Medea Scientific Institute, Lecco, Italy.
Wolfson Institute for Biomedical Research, University College London, London, United Kingdom
| | - Michele O. Carruba
- Integrated Laboratories Network, Center for Study and Research on Obesity, Department of Pharmacology, School of Medicine, University of Milan, Milan, Italy.
Department of Preclinical Sciences, University of Milan, Milan, Italy.
CEINGE Biotecnologie Avanzate, Naples, Italy.
Istituto Auxologico Italiano, Milan, Italy.
Stem Cell Research Institute, San Raffaele Scientific Institute, Milan, Italy.
Istituto di Farmacologia e Farmacognosia, University of Urbino “Carlo Bo,” Urbino, Italy.
Eugenio Medea Scientific Institute, Lecco, Italy.
Wolfson Institute for Biomedical Research, University College London, London, United Kingdom
| | - Enzo Nisoli
- Integrated Laboratories Network, Center for Study and Research on Obesity, Department of Pharmacology, School of Medicine, University of Milan, Milan, Italy.
Department of Preclinical Sciences, University of Milan, Milan, Italy.
CEINGE Biotecnologie Avanzate, Naples, Italy.
Istituto Auxologico Italiano, Milan, Italy.
Stem Cell Research Institute, San Raffaele Scientific Institute, Milan, Italy.
Istituto di Farmacologia e Farmacognosia, University of Urbino “Carlo Bo,” Urbino, Italy.
Eugenio Medea Scientific Institute, Lecco, Italy.
Wolfson Institute for Biomedical Research, University College London, London, United Kingdom
| |
Collapse
|
2411
|
Macia L, Viltart O, Verwaerde C, Delacre M, Delanoye A, Grangette C, Wolowczuk I. Genes involved in obesity: Adipocytes, brain and microflora. GENES & NUTRITION 2006; 1:189-212. [PMID: 18850214 PMCID: PMC3454837 DOI: 10.1007/bf02829968] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/19/2023]
Abstract
The incidence of obesity and related metabolic disorders such as cardiovascular diseases and type 2 diabetes, are reaching worldwide epidemic proportions. It results from an imbalance between caloric intake and energy expenditure leading to excess energy storage, mostly due to genetic and environmental factors such as diet, food components and/or way of life. It is known since long that this balance is maintained to equilibrium by multiple mechanisms allowing the brain to sense the nutritional status of the body and adapt behavioral and metabolic responses to changes in fuel availability. In this review, we summarize selected aspects of the regulation of energy homeostasis, prevalently highlighting the complex relationships existing between the white adipose tissue, the central nervous system, the endogenous microbiota, and nutrition. We first describe how both the formation and functionality of adipose cells are strongly modulated by the diet before summarizing where and how the central nervous system integrates peripheral signals from the adipose tissue and/or the gastro-intestinal tract. Finally, after a short description of the intestinal commensal flora, rangingfrom its composition to its importance in immune surveillance, we enlarge the discussion on how nutrition modified this perfectly well-balanced ecosystem.
Collapse
Affiliation(s)
- L. Macia
- Laboratoire de Neuro-Immuno-Endocrinologie, Institut Pasteur de Lille /1 FR 142, 1, rue A. Calmette, BP 447, 59019 Lille cedex, France
| | - O. Viltart
- Unité de Neurosciences et de Physiologie Adaptatives SN4, Université de Lille I, 59655 Villeneuve d’Ascq, France
| | - C. Verwaerde
- Laboratoire de Neuro-Immuno-Endocrinologie, Institut Pasteur de Lille /1 FR 142, 1, rue A. Calmette, BP 447, 59019 Lille cedex, France
| | - M. Delacre
- Laboratoire de Neuro-Immuno-Endocrinologie, Institut Pasteur de Lille /1 FR 142, 1, rue A. Calmette, BP 447, 59019 Lille cedex, France
| | - A. Delanoye
- Laboratoire de Neuro-Immuno-Endocrinologie, Institut Pasteur de Lille /1 FR 142, 1, rue A. Calmette, BP 447, 59019 Lille cedex, France
| | - C. Grangette
- Bactéries Lactiques et Immunité des Muqueuses, Institut Pasteur de Lille / Institut de Biologie de Lille, 1, rue A. Calmette, BP 447, 59019 Lille cedex, France
| | - I. Wolowczuk
- Laboratoire de Neuro-Immuno-Endocrinologie, Institut Pasteur de Lille /1 FR 142, 1, rue A. Calmette, BP 447, 59019 Lille cedex, France
| |
Collapse
|
2412
|
Affiliation(s)
- P J White
- Department of Anatomy-Physiology and Lipid Research Unit, Laval University Hospital Research Centre, 2705 Laurier Blvd, G1V 4G2, Ste-Foy, QC, Canada.
| | | |
Collapse
|
2413
|
Lagathu C, Yvan-Charvet L, Bastard JP, Maachi M, Quignard-Boulangé A, Capeau J, Caron M. Long-term treatment with interleukin-1beta induces insulin resistance in murine and human adipocytes. Diabetologia 2006; 49:2162-73. [PMID: 16865359 DOI: 10.1007/s00125-006-0335-z] [Citation(s) in RCA: 221] [Impact Index Per Article: 12.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/22/2006] [Accepted: 05/04/2006] [Indexed: 12/22/2022]
Abstract
AIMS/HYPOTHESIS Adipose tissue inflammation has recently been implicated in the pathogenesis of insulin resistance and is probably linked to high local levels of cytokines. IL1B, a proinflammatory cytokine, may participate in this alteration. MATERIALS AND METHODS We evaluated the chronic effect (1-10 days) of IL1B (0.1-20 ng/ml) on insulin signalling in differentiating 3T3-F442A and differentiated 3T3-L1 murine adipocytes and in human adipocytes. We also assessed expression of the gene encoding IL1B in adipose tissue of wild-type and insulin-resistant mice (diet-induced and genetically obese ob/ob mice). RESULTS IL1B inhibited insulin-induced phosphorylation of the insulin receptor beta subunit, insulin receptor substrate 1, Akt/protein kinase B and extracellular regulated kinase 1/2 in murine and human adipocytes. Accordingly, IL1B suppressed insulin-induced glucose transport and lipogenesis. Long-term treatment of adipose cells with IL1B decreased cellular lipid content. This could result from enhanced lipolysis and/or decreased expression of genes involved in lipid metabolism (acetyl-CoA carboxylase, fatty acid synthase). Down-regulation of peroxisome proliferating-activated receptor gamma and CCAAT/enhancer-binding protein alpha in response to IL1B may have contributed to the altered phenotype of IL1B-treated adipocytes. Moreover, IL1B altered adipocyte differentiation status in long-term cultures. IL1B also decreased the production of adiponectin, an adipocyte-specific protein that plays a positive role in insulin sensitivity. Expression of the gene encoding IL1B was increased in epididymal adipose tissue of obese insulin-resistant mice. CONCLUSIONS/INTERPRETATION IL1B is upregulated in adipose tissue of obese and insulin-resistant mouse models and may play an important role in the development of insulin resistance in murine and human adipose cells.
Collapse
Affiliation(s)
- C Lagathu
- INSERM, U680, Université Pierre et Marie Curie (UPMC-Paris 6), Faculty of Medicine, 27 rue Chaligny, 75012, Paris, France
| | | | | | | | | | | | | |
Collapse
|
2414
|
Todoric J, Löffler M, Huber J, Bilban M, Reimers M, Kadl A, Zeyda M, Waldhäusl W, Stulnig TM. Adipose tissue inflammation induced by high-fat diet in obese diabetic mice is prevented by n-3 polyunsaturated fatty acids. Diabetologia 2006; 49:2109-19. [PMID: 16783472 DOI: 10.1007/s00125-006-0300-x] [Citation(s) in RCA: 193] [Impact Index Per Article: 10.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 12/16/2005] [Accepted: 05/22/2006] [Indexed: 01/22/2023]
Abstract
AIMS/HYPOTHESIS Inflammatory alterations in white adipose tissue appear to underlie complications of obesity including diabetes mellitus. Polyunsaturated fatty acids (PUFA), particularly those of the n-3 series, modulate immune responses and may ameliorate insulin sensitivity. In this study, we investigated how PUFA affect white adipose tissue inflammation and gene expression in obese diabetic animals. MATERIALS AND METHODS We treated db/db mice as well as lean non-diabetic mice (db/+) with either low-fat standard diet (LF) or high-fat diets rich in (1) saturated/monounsaturated fatty acids (HF/S), (2) n-6 PUFA (HF/6) and (3) the latter including purified marine n-3 PUFA (HF/3). RESULTS Many genes involved in inflammatory alterations were upregulated in db/db mice on HF/S compared with LF in parallel with phosphorylation of c-Jun N-terminal kinase (JNK). In parallel, adipose tissue infiltration with macrophages was markedly enhanced by HF/S. When compared with HF/S, HF/6 showed only marginal effects on adipose tissue inflammation. However, inclusion of n-3 PUFA in the diet (HF/3) completely prevented macrophage infiltration induced by high-fat diet and changes in inflammatory gene expression, also tending to reduce JNK phosphorylation (p<0.1) in diabetic mice despite unreduced body weight. Moreover, high-fat diets (HF/S, HF/6) downregulated expression and reduced serum concentrations of adiponectin, but this was not the case with n-3 PUFA. CONCLUSIONS/INTERPRETATION n-3 PUFA prevent adipose tissue inflammation induced by high-fat diet in obese diabetic mice, thereby dissecting obesity from adipose tissue inflammation. These data suggest that beneficial effects of n-3 PUFA on diabetes development could be mediated by their effect on adipose tissue inflammation.
Collapse
Affiliation(s)
- J Todoric
- Clinical Division of Endocrinology and Metabolism, Department of Internal Medicine III, Medical University of Vienna, Währinger Gürtel 18-20, 1090, Vienna, Austria
| | | | | | | | | | | | | | | | | |
Collapse
|
2415
|
Peeraully MR, Sievert H, Bulló M, Wang B, Trayhurn P. Prostaglandin D2 and J2-series (PGJ2, Delta12-PGJ2) prostaglandins stimulate IL-6 and MCP-1, but inhibit leptin, expression and secretion by 3T3-L1 adipocytes. Pflugers Arch 2006; 453:177-87. [PMID: 16924534 DOI: 10.1007/s00424-006-0118-x] [Citation(s) in RCA: 22] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/25/2006] [Revised: 06/01/2006] [Accepted: 06/09/2006] [Indexed: 12/22/2022]
Abstract
Prostaglandin D(2) and its derivatives PGJ(2) and Delta(12)-PGJ(2) strongly stimulate the synthesis and secretion by white adipocytes of the neurotrophin NGF. Here we have explored whether PGD(2) and the J(2)-series prostaglandins have pervasive effects on adipokine production. The influence of these prostaglandins on the production of the adipocyte hormones leptin and adiponectin, and the inflammatory factors IL-6 and monocyte chemoattractant protein 1 (MCP-1), were examined in 3T3-L1 adipocytes. PGD(2) induced a reduction in adiponectin and leptin mRNA, and the secretion of these adipokines was also inhibited, the effect being greater with leptin (up to 10-fold) than with adiponectin (twofold). In contrast, PGD(2) induced a marked stimulation of IL-6 and MCP-1 expression; with IL-6, this was rapid, the mRNA level increasing by >50-fold by 1 h. The rise in mRNA was accompanied by an increase in IL-6 and MCP-1 release (up to 100- and 6.5-fold, respectively). The effects of PGD(2) were generally mirrored by PGJ(2) and Delta(12)-PGJ(2); Delta(12)-PGJ(2) was a particularly strong stimulator of IL-6 production. These results indicate that PGD(2) and the J(2)-series prostaglandins PGJ(2) and Delta(12)-PGJ(2) can have major effects on the synthesis and release of key adipokines. Such effects could be important in the inflammatory response in adipose tissue.
Collapse
Affiliation(s)
- Muhammad R Peeraully
- Obesity Biology Unit, Liverpool Centre for Nutritional Genomics and Liverpool Obesity Research Network, Division of Metabolic and Cellular Medicine, University of Liverpool, Duncan Building, Liverpool, UK
| | | | | | | | | |
Collapse
|
2416
|
Giri S, Rattan R, Haq E, Khan M, Yasmin R, Won JS, Key L, Singh AK, Singh I. AICAR inhibits adipocyte differentiation in 3T3L1 and restores metabolic alterations in diet-induced obesity mice model. Nutr Metab (Lond) 2006; 3:31. [PMID: 16901342 PMCID: PMC1564022 DOI: 10.1186/1743-7075-3-31] [Citation(s) in RCA: 150] [Impact Index Per Article: 8.3] [Reference Citation Analysis] [Abstract] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/05/2006] [Accepted: 08/10/2006] [Indexed: 12/15/2022] Open
Abstract
Background Obesity is one of the principal causative factors involved in the development of metabolic syndrome. AMP-activated protein kinase (AMPK) is an energy sensor that regulates cellular metabolism. The role of AMP-activated protein kinase in adipocyte differentiation is not completely understood, therefore, we examined the effect of 5-aminoimidazole-4-carboxamide-1-β-D-ribofuranoside (AICAR), a pharmacological activator of AMP-activated protein kinase (AMPK) on adipocyte differentiation in 3T3L1 cells and in a mouse Diet induced obesity (DIO) model. Methods To examine the effect of AICAR on adipocyte differentiation in 3T3L1 cells and in a mouse Diet induced obesity (DIO) model, 3T3L1 cells were differentiatied in the presence or absence of different concentration of AICAR and neutral lipid content and expression of various adipocyte-specific transcription factors were examined. In vivo study, treated and untreated mice with AICAR (0.1–0.5 mg/g body weight) were fed high-fat diet (60% kcal% fat) to induce DIO and several parameters were studied. Results AICAR blocked adipogenic conversion in 3T3L1 cells along with significant decrease in the neutral lipid content by downregulating several adipocyte-specific transcription factors including peroxisome proliferators-activated receptor γ (PPARγ), C/EBPα and ADD1/SREBP1, which are critical for adipogenesis in vitro. Moreover, intraperitoneal administration of AICAR (0.5 mg g/body weight) to mice fed with high-fat diet (60% kcal% fat) to induce DIO, significantly blocked the body weight gain and total content of epididymal fat in these mice over a period of 6 weeks. AICAR treatment also restored normal adipokine levels and resulted in significant improvement in glucose tolerance and insulin sensitivity. The reduction in adipose tissue content in AICAR treated DIO mice was due to reduction in lipid accumulation in the pre-existing adipocytes. However, no change was observed in the expression of PPARγ, C/EBPα and ADD1/SREBP1 transcription factors in vivo though PGC1α expression was significantly induced. Conclusion This study suggests that AICAR inhibits adipocyte differentiation via downregulation of expression of adipogenic factors in vitro and reduces adipose tissue content in DIO mice by activating expression of PGC1α without inhibiting adipocyte-specific transcription factors in DIO mice.
Collapse
Affiliation(s)
- Shailendra Giri
- Department of Pediatrics, Medical University of South Carolina, Charleston, SC 29425, USA
| | - Ramandeep Rattan
- Division of Experimental Pathology, Department of Laboratory Medicine and Pathology, Mayo Clinic/Foundation, 200 First Street, SW Rochester, MN 55905, USA
| | - Ehtishamul Haq
- Department of Pediatrics, Medical University of South Carolina, Charleston, SC 29425, USA
| | - Mushfiquddin Khan
- Department of Pediatrics, Medical University of South Carolina, Charleston, SC 29425, USA
| | - Rifat Yasmin
- Department of Pediatrics, Medical University of South Carolina, Charleston, SC 29425, USA
| | - Je-song Won
- Department of Pathology, Medical University of South Carolina, Charleston, SC 29425, USA
| | - Lyndon Key
- Department of Pediatrics, Medical University of South Carolina, Charleston, SC 29425, USA
| | - Avtar K Singh
- Department of Pathology and Laboratory Medicine, Ralph Johnson Veterans Affairs Medical Center, Charleston, SC 29425, USA
| | - Inderjit Singh
- Department of Pediatrics, Medical University of South Carolina, Charleston, SC 29425, USA
| |
Collapse
|
2417
|
Karvounaris SA, Sidiropoulos PI, Papadakis JA, Spanakis EK, Bertsias GK, Kritikos HD, Ganotakis ES, Boumpas DT. Metabolic syndrome is common among middle-to-older aged Mediterranean patients with rheumatoid arthritis and correlates with disease activity: a retrospective, cross-sectional, controlled, study. Ann Rheum Dis 2006; 66:28-33. [PMID: 16793841 PMCID: PMC1798406 DOI: 10.1136/ard.2006.053488] [Citation(s) in RCA: 96] [Impact Index Per Article: 5.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
Abstract
OBJECTIVES Patients with rheumatoid arthritis have an increased risk for cardiovascular disease (CVD). The prevalence of metabolic syndrome (MetS)-a major contributor to CVD-in a cohort of patients with rheumatoid arthritis and its relationship with rheumatoid arthritis related factors is investigated here. METHODS 200 outpatients with rheumatoid arthritis (147 women and 53 men), with a mean (standard deviation (SD)) age of 63 (11) years, and 400 age and sex-matched controls were studied. MetS was assessed according to the adult treatment panel III criteria and rheumatoid arthritis disease activity by the disease activity score of 28 joints (DAS28). A standard clinical evaluation was carried out, and a health and lifestyle questionnaire was completed. RESULTS The overall prevalence of MetS was 44% in patients with rheumatoid arthritis and 41% in controls (p = 0.5). Patients with rheumatoid arthritis were more likely to have low high-density lipoprotein cholesterol compared with controls (p = 0.02), whereas controls were more likely to have increased waist circumference or raised blood pressure (p = 0.001 and 0.003, respectively). In multivariate logistic regression analysis adjusting for demographics and rheumatoid arthritis treatment modalities, the risk of having moderate-to-high disease activity (DAS28>3.2) was significantly higher in patients with MetS compared with those with no MetS components (OR 9.24, 95% CI 1.49 to 57.2, p = 0.016). CONCLUSION A high, albeit comparable to the control population, prevalence of MetS was found in middle-to-older aged patients with rheumatoid arthritis. The correlation of rheumatoid arthritis disease activity with MetS suggests that the increased prevalence of coronary heart disease in patients with rheumatoid arthritis may, at least in part, be attributed to the inflammatory burden of the disease.
Collapse
Affiliation(s)
- S A Karvounaris
- Division of Rheumatology, Clinical Immunology and Allergy, University of Crete, Medical School, Voutes 71500, Heraklion, Greece
| | | | | | | | | | | | | | | |
Collapse
|
2418
|
Abstract
Inflammation long has been recognized as a hallmark of atherosclerotic lesions, but more recently attention has focused on chronic low-level elevations of specific plasma inflammatory proteins such as C-reactive protein (CRP) and serum amyloid A (SAA), which may not only represent markers of atherosclerosis risk but also participate directly in atherogenesis. This article briefly reviews evidence for and against potential roles of CRP as an atherosclerosis risk marker and in athero-genesis. The remainder of the article focuses on SAA, an inflammatory protein that is carried on, and may fundamentally alter the function of, high-density lipoprotein. Data are reviewed regarding the regulation of SAA by dietary cholesterol, obesity, and insulin resistance, and its potential role as an atherosclerosis mediator. Lying at the intersection of inflammation, dyslipidemia, obesity, and insulin resistance, SAA may play a key role in regulating the contributions of these processes to atherogenesis.
Collapse
Affiliation(s)
- Kevin D O'Brien
- Division of Cardiology, University of Washington, Seattle 98195-6422, USA.
| | | |
Collapse
|
2419
|
Hansen E, Hajri T, Abumrad NN. Is all fat the same? The role of fat in the pathogenesis of the metabolic syndrome and type 2 diabetes mellitus. Surgery 2006; 139:711-6. [PMID: 16782424 PMCID: PMC3182097 DOI: 10.1016/j.surg.2005.10.018] [Citation(s) in RCA: 26] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/27/2005] [Accepted: 10/20/2005] [Indexed: 11/19/2022]
Affiliation(s)
- Erik Hansen
- Department of Surgery, Vanderbilt University School of Medicine, Nashville, Tennessee 37232, USA
| | | | | |
Collapse
|
2420
|
Abstract
Plasma free fatty acid (FFA) levels are elevated in obesity. FFA, by causing insulin resistance in muscle, liver, and endothelial cells, contributes to the development of type 2 diabetes mellitus (T2DM), hypertension, dyslipidemia, and nonalcoholic fatty liver disease (NAFLD). The mechanism through which FFA induces insulin resistance involves intramyocellular and intrahepatocellular accumulation of triglycerides and diacylglycerol, activation of several serine/threonine kinases, reduction in tyrosine phosphorylation of the insulin receptor substrate (IRS)-1/2, and impairment of the IRS/phosphatidylinositol 3-kinase pathway of insulin signaling. FFA also produces low-grade inflammation in skeletal muscle and liver through activation of nuclear factor-kappaB, resulting in release of several proinflammatory and proatherogenic cytokines. Thus, elevated FFA levels (due to obesity or to high-fat feeding) cause insulin resistance in skeletal muscle and liver, which contributes to the development of T2DM, and produce low-grade inflammation, which contributes to the development of atherosclerotic vascular diseases and NAFLD.
Collapse
Affiliation(s)
- Guenther Boden
- Division of Endocrinology/Diabetes/Metabolism, Temple University School of Medicine, Temple University Hospital, 3401 North Broad Street, Philadelphia, PA 19140, USA.
| |
Collapse
|
2421
|
Yang RZ, Lee MJ, Hu H, Pollin TI, Ryan AS, Nicklas BJ, Snitker S, Horenstein RB, Hull K, Goldberg NH, Goldberg AP, Shuldiner AR, Fried SK, Gong DW. Acute-phase serum amyloid A: an inflammatory adipokine and potential link between obesity and its metabolic complications. PLoS Med 2006; 3:e287. [PMID: 16737350 PMCID: PMC1472697 DOI: 10.1371/journal.pmed.0030287] [Citation(s) in RCA: 247] [Impact Index Per Article: 13.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 03/04/2005] [Accepted: 02/28/2006] [Indexed: 02/06/2023] Open
Abstract
BACKGROUND Obesity is associated with low-grade chronic inflammation, and serum markers of inflammation are independent risk factors for cardiovascular disease (CVD). However, the molecular and cellular mechanisms that link obesity to chronic inflammation and CVD are poorly understood. METHODS AND FINDINGS Acute-phase serum amyloid A (A-SAA) mRNA levels, and A-SAA adipose secretion and serum levels were measured in obese and nonobese individuals, obese participants who underwent weight-loss, and persons treated with the insulin sensitizer rosiglitazone. Inflammation-eliciting activity of A-SAA was investigated in human adipose stromal vascular cells, coronary vascular endothelial cells and a murine monocyte cell line. We demonstrate that A-SAA was highly and selectively expressed in human adipocytes. Moreover, A-SAA mRNA levels and A-SAA secretion from adipose tissue were significantly correlated with body mass index (r = 0.47; p = 0.028 and r = 0.80; p = 0.0002, respectively). Serum A-SAA levels decreased significantly after weight loss in obese participants (p = 0.006), as well as in those treated with rosiglitazone (p = 0.033). The magnitude of the improvement in insulin sensitivity after weight loss was significantly correlated with decreases in serum A-SAA (r = -0.74; p = 0.034). SAA treatment of vascular endothelial cells and monocytes markedly increased the production of inflammatory cytokines, e.g., interleukin (IL)-6, IL-8, tumor necrosis factor alpha, and monocyte chemoattractant protein-1. In addition, SAA increased basal lipolysis in adipose tissue culture by 47%. CONCLUSIONS A-SAA is a proinflammatory and lipolytic adipokine in humans. The increased expression of A-SAA by adipocytes in obesity suggests that it may play a critical role in local and systemic inflammation and free fatty acid production and could be a direct link between obesity and its comorbidities, such as insulin resistance and atherosclerosis. Accordingly, improvements in systemic inflammation and insulin resistance with weight loss and rosiglitazone therapy may in part be mediated by decreases in adipocyte A-SAA production.
Collapse
Affiliation(s)
- Rong-Ze Yang
- 1Division of Endocrinology, Diabetes, and Nutrition, University of Maryland School of Medicine, Baltimore, Maryland, United States of America
| | - Mi-Jeong Lee
- 1Division of Endocrinology, Diabetes, and Nutrition, University of Maryland School of Medicine, Baltimore, Maryland, United States of America
| | - Hong Hu
- 1Division of Endocrinology, Diabetes, and Nutrition, University of Maryland School of Medicine, Baltimore, Maryland, United States of America
| | - Toni I Pollin
- 1Division of Endocrinology, Diabetes, and Nutrition, University of Maryland School of Medicine, Baltimore, Maryland, United States of America
| | - Alice S Ryan
- 2Division of Gerontology, Geriatric Research, Education, and Clinical Center, Baltimore Veterans Administration Medical Center, Baltimore, Maryland, United States of America
| | - Barbara J Nicklas
- 3Section on Gerontology and Geriatric Medicine, Wake Forest University School of Medicine, Winston-Salem, North Carolina, United States of America
| | - Soren Snitker
- 1Division of Endocrinology, Diabetes, and Nutrition, University of Maryland School of Medicine, Baltimore, Maryland, United States of America
| | - Richard B Horenstein
- 1Division of Endocrinology, Diabetes, and Nutrition, University of Maryland School of Medicine, Baltimore, Maryland, United States of America
| | - Kristen Hull
- 1Division of Endocrinology, Diabetes, and Nutrition, University of Maryland School of Medicine, Baltimore, Maryland, United States of America
| | - Nelson H Goldberg
- 4Division of Plastic and Reconstructive Surgery, University of Maryland School of Medicine, Baltimore, Maryland, United States of America
| | - Andrew P Goldberg
- 2Division of Gerontology, Geriatric Research, Education, and Clinical Center, Baltimore Veterans Administration Medical Center, Baltimore, Maryland, United States of America
| | - Alan R Shuldiner
- 1Division of Endocrinology, Diabetes, and Nutrition, University of Maryland School of Medicine, Baltimore, Maryland, United States of America
- 2Division of Gerontology, Geriatric Research, Education, and Clinical Center, Baltimore Veterans Administration Medical Center, Baltimore, Maryland, United States of America
| | - Susan K Fried
- 1Division of Endocrinology, Diabetes, and Nutrition, University of Maryland School of Medicine, Baltimore, Maryland, United States of America
- 2Division of Gerontology, Geriatric Research, Education, and Clinical Center, Baltimore Veterans Administration Medical Center, Baltimore, Maryland, United States of America
| | - Da-Wei Gong
- 1Division of Endocrinology, Diabetes, and Nutrition, University of Maryland School of Medicine, Baltimore, Maryland, United States of America
- * To whom correspondence should be addressed. E-mail:
| |
Collapse
|
2422
|
Kanda H, Tateya S, Tamori Y, Kotani K, Hiasa KI, Kitazawa R, Kitazawa S, Miyachi H, Maeda S, Egashira K, Kasuga M. MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity. J Clin Invest 2006; 116:1494-505. [PMID: 16691291 PMCID: PMC1459069 DOI: 10.1172/jci26498] [Citation(s) in RCA: 1954] [Impact Index Per Article: 108.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/04/2005] [Accepted: 03/14/2006] [Indexed: 12/13/2022] Open
Abstract
Adipocytes secrete a variety of bioactive molecules that affect the insulin sensitivity of other tissues. We now show that the abundance of monocyte chemoattractant protein-1 (MCP-1) mRNA in adipose tissue and the plasma concentration of MCP-1 were increased both in genetically obese diabetic (db/db) mice and in WT mice with obesity induced by a high-fat diet. Mice engineered to express an MCP-1 transgene in adipose tissue under the control of the aP2 gene promoter exhibited insulin resistance, macrophage infiltration into adipose tissue, and increased hepatic triglyceride content. Furthermore, insulin resistance, hepatic steatosis, and macrophage accumulation in adipose tissue induced by a high-fat diet were reduced extensively in MCP-1 homozygous KO mice compared with WT animals. Finally, acute expression of a dominant-negative mutant of MCP-1 ameliorated insulin resistance in db/db mice and in WT mice fed a high-fat diet. These findings suggest that an increase in MCP-1 expression in adipose tissue contributes to the macrophage infiltration into this tissue, insulin resistance, and hepatic steatosis associated with obesity in mice.
Collapse
Affiliation(s)
- Hajime Kanda
- Department of Clinical Molecular Medicine, Kobe University Graduate School of Medicine, Kobe, Japan.
Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Department of Biomedical Informatics, Kobe University Graduate School of Medicine, Kobe, Japan.
Laboratory for Animal Resources and Genetic Engineering, Center for Developmental Biology (CDB), Institute of Physical and Chemical Research (RIKEN), Kobe, Japan
| | - Sanshiro Tateya
- Department of Clinical Molecular Medicine, Kobe University Graduate School of Medicine, Kobe, Japan.
Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Department of Biomedical Informatics, Kobe University Graduate School of Medicine, Kobe, Japan.
Laboratory for Animal Resources and Genetic Engineering, Center for Developmental Biology (CDB), Institute of Physical and Chemical Research (RIKEN), Kobe, Japan
| | - Yoshikazu Tamori
- Department of Clinical Molecular Medicine, Kobe University Graduate School of Medicine, Kobe, Japan.
Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Department of Biomedical Informatics, Kobe University Graduate School of Medicine, Kobe, Japan.
Laboratory for Animal Resources and Genetic Engineering, Center for Developmental Biology (CDB), Institute of Physical and Chemical Research (RIKEN), Kobe, Japan
| | - Ko Kotani
- Department of Clinical Molecular Medicine, Kobe University Graduate School of Medicine, Kobe, Japan.
Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Department of Biomedical Informatics, Kobe University Graduate School of Medicine, Kobe, Japan.
Laboratory for Animal Resources and Genetic Engineering, Center for Developmental Biology (CDB), Institute of Physical and Chemical Research (RIKEN), Kobe, Japan
| | - Ken-ichi Hiasa
- Department of Clinical Molecular Medicine, Kobe University Graduate School of Medicine, Kobe, Japan.
Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Department of Biomedical Informatics, Kobe University Graduate School of Medicine, Kobe, Japan.
Laboratory for Animal Resources and Genetic Engineering, Center for Developmental Biology (CDB), Institute of Physical and Chemical Research (RIKEN), Kobe, Japan
| | - Riko Kitazawa
- Department of Clinical Molecular Medicine, Kobe University Graduate School of Medicine, Kobe, Japan.
Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Department of Biomedical Informatics, Kobe University Graduate School of Medicine, Kobe, Japan.
Laboratory for Animal Resources and Genetic Engineering, Center for Developmental Biology (CDB), Institute of Physical and Chemical Research (RIKEN), Kobe, Japan
| | - Sohei Kitazawa
- Department of Clinical Molecular Medicine, Kobe University Graduate School of Medicine, Kobe, Japan.
Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Department of Biomedical Informatics, Kobe University Graduate School of Medicine, Kobe, Japan.
Laboratory for Animal Resources and Genetic Engineering, Center for Developmental Biology (CDB), Institute of Physical and Chemical Research (RIKEN), Kobe, Japan
| | - Hitoshi Miyachi
- Department of Clinical Molecular Medicine, Kobe University Graduate School of Medicine, Kobe, Japan.
Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Department of Biomedical Informatics, Kobe University Graduate School of Medicine, Kobe, Japan.
Laboratory for Animal Resources and Genetic Engineering, Center for Developmental Biology (CDB), Institute of Physical and Chemical Research (RIKEN), Kobe, Japan
| | - Sakan Maeda
- Department of Clinical Molecular Medicine, Kobe University Graduate School of Medicine, Kobe, Japan.
Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Department of Biomedical Informatics, Kobe University Graduate School of Medicine, Kobe, Japan.
Laboratory for Animal Resources and Genetic Engineering, Center for Developmental Biology (CDB), Institute of Physical and Chemical Research (RIKEN), Kobe, Japan
| | - Kensuke Egashira
- Department of Clinical Molecular Medicine, Kobe University Graduate School of Medicine, Kobe, Japan.
Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Department of Biomedical Informatics, Kobe University Graduate School of Medicine, Kobe, Japan.
Laboratory for Animal Resources and Genetic Engineering, Center for Developmental Biology (CDB), Institute of Physical and Chemical Research (RIKEN), Kobe, Japan
| | - Masato Kasuga
- Department of Clinical Molecular Medicine, Kobe University Graduate School of Medicine, Kobe, Japan.
Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Department of Biomedical Informatics, Kobe University Graduate School of Medicine, Kobe, Japan.
Laboratory for Animal Resources and Genetic Engineering, Center for Developmental Biology (CDB), Institute of Physical and Chemical Research (RIKEN), Kobe, Japan
| |
Collapse
|
2423
|
Bays H, Dujovne CA. Adiposopathy is a more rational treatment target for metabolic disease than obesity alone. Curr Atheroscler Rep 2006; 8:144-56. [PMID: 16510049 DOI: 10.1007/s11883-006-0052-6] [Citation(s) in RCA: 37] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/06/2023]
Abstract
Current guidelines recommend that weight-loss therapy should be primarily based upon specific body mass index (BMI) cut-off limits. However, in the adipocentric paradigm, it is acknowledged that co-morbidities, such as type 2 diabetes mellitus, hypertension, and dyslipidemia, occur at all levels of BMI. Excessive fat mass (adiposity) in genetically susceptible individuals results in fat dysfunction (adiposopathy), which then contributes to metabolic disorders that increase the risk of atherosclerotic cardiovascular disease. In this paradigm, the term "anti-obesity" treatment might best be replaced by "anti-adiposopathy" treatment, wherein the focus is not based solely on BMI, but instead directed towards physiologically improving fat cell function and clinically improving the metabolic health of patients. This may occur through appropriate diet, physical exercise, and other lifestyle changes, and/or from drug therapies. Cannabinoid receptor antagonists and peroxisome proliferator activated receptor agonists are examples of agents that physiologically improve fat function and clinically improve metabolic disease.
Collapse
Affiliation(s)
- Harold Bays
- L-MARC Research Center, 3288 Illinois Avenue, Louisville, KY 40213, USA.
| | | |
Collapse
|
2424
|
Abstract
Type 2 Diabetes results from a complex physiologic process that includes the pancreatic beta cells, peripheral glucose uptake in muscle, the secretion of multiple cytokines and hormone-like molecules from adipocytes, hepatic glucose production, and likely the central nervous system. Consistent with the complex web of physiologic defects, the emerging picture of the genetics will involve a large number of risk susceptibility genes, each individually with relatively small effect (odds ratios below 1.2 in most cases). The challenge for the future will include cataloging and confirming the genetic risk factors, and understanding how these risk factors interact with each other and with the known environmental and lifestyle risk factors that increase the propensity to type 2 diabetes.
Collapse
Affiliation(s)
- Swapan Kumar Das
- University of Arkansas for Medical Sciences and Central Arkansas Veterans Healthcare System, Little Rock, Arkansas
| | | |
Collapse
|
2425
|
Abstract
The nuclear receptor family of PPARs was named for the ability of the original member to induce hepatic peroxisome proliferation in mice in response to xenobiotic stimuli. However, studies on the action and structure of the 3 human PPAR isotypes (PPARalpha, PPARdelta, and PPARgamma) suggest that these moieties are intimately involved in nutrient sensing and the regulation of carbohydrate and lipid metabolism. PPARalpha and PPARdelta appear primarily to stimulate oxidative lipid metabolism, while PPARgamma is principally involved in the cellular assimilation of lipids via anabolic pathways. Our understanding of the functions of PPARgamma in humans has been increased by the clinical use of potent agonists and by the discovery of both rare and severely deleterious dominant-negative mutations leading to a stereotyped syndrome of partial lipodystrophy and severe insulin resistance, as well as more common sequence variants with a much smaller impact on receptor function. These may nevertheless have much greater significance for the public health burden of metabolic disease. This Review will focus on the role of PPARgamma in human physiology, with specific reference to clinical pharmacological studies, and analysis of PPARG gene variants in the abnormal lipid and carbohydrate metabolism of the metabolic syndrome.
Collapse
Affiliation(s)
- Robert K Semple
- Department of Clinical Biochemistry, University of Cambridge, Addenbrooke's Hospital, Cambridge, United Kingdom
| | | | | |
Collapse
|
2426
|
Karagiannides I, Kokkotou E, Tansky M, Tchkonia T, Giorgadze N, O'Brien M, Leeman SE, Kirkland JL, Pothoulakis C. Induction of colitis causes inflammatory responses in fat depots: evidence for substance P pathways in human mesenteric preadipocytes. Proc Natl Acad Sci U S A 2006; 103:5207-12. [PMID: 16549770 PMCID: PMC1458819 DOI: 10.1073/pnas.0600821103] [Citation(s) in RCA: 66] [Impact Index Per Article: 3.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/18/2022] Open
Abstract
Intracolonic administration of trinitrobenzene sulfonic acid in mice causes inflammation in the colon that is accompanied by increased expression of proinflammatory cytokines and of the substance P (SP), neurokinin 1 receptor (NK-1R) in the proximal mesenteric fat depot. We also investigated whether human mesenteric preadipocytes contain NK-1R and examined the functional consequences of exposure of these cells to SP as it relates to proinflammatory signaling. We found that human mesenteric preadipocytes express NK-1R both at the mRNA and protein levels. Exposure of human mesenteric preadipocytes to SP increased NK-1R mRNA and protein expression by 3-fold, and stimulated IL-8 mRNA expression and protein secretion. This effect was abolished when these cells were pretreated with the specific NK-1R antagonist CJ 012,255. Moreover, human mesenteric preadipocytes transfected with a luciferase promoter/reporter system containing the IL-8 promoter with a mutated NF-kappaB site lost their ability to respond to SP, indicating that SP-induced IL-8 expression is NF-kappaB-dependent. This report indicates that human mesenteric preadipocytes contain functional SP receptors that are linked to proinflammatory pathways, and that SP can directly increase NK-1R expression. We speculate that mesenteric fat depots may participate in intestinal inflammatory responses via SP-NK-1R-related pathways, as well as other systemic responses to the presence of an ongoing inflammation of the colon.
Collapse
Affiliation(s)
- Iordanes Karagiannides
- *Gastrointestinal Neuropeptide Center, Division of Gastroenterology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215; and Departments of
| | - Efi Kokkotou
- *Gastrointestinal Neuropeptide Center, Division of Gastroenterology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215; and Departments of
| | | | | | | | - Michael O'Brien
- Pathology, Boston University School of Medicine, Boston, MA 02118
| | - Susan E. Leeman
- Pharmacology
- To whom correspondence may be addressed. E-mail:
| | | | - Charalabos Pothoulakis
- *Gastrointestinal Neuropeptide Center, Division of Gastroenterology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215; and Departments of
- **To whom correspondence may be addressed at:
Gastrointestinal Neuropeptide Center, Division of Gastroenterology, Beth Israel Deaconess Medical Center, Harvard Medical School, Dana 601, 330 Brookline Avenue, Boston, MA 02215. E-mail:
| |
Collapse
|
2427
|
Babic AM, Wang HW, Lai MJ, Daniels TG, Felbinger TW, Burger PC, Stricker-Krongrad A, Wagner DD. ICAM-1 and beta2 integrin deficiency impairs fat oxidation and insulin metabolism during fasting. Mol Med 2006; 10:72-9. [PMID: 15706402 PMCID: PMC1431368 DOI: 10.2119/2004-00038.wagner] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/06/2004] [Accepted: 10/18/2004] [Indexed: 11/06/2022] Open
Abstract
Intercellular adhesion molecule 1 (ICAM-1) and beta2 integrins play critical roles in immune responses. ICAM-1 may also participate in regulation of energy balance because ICAM-1-deficient mice become obese on a high-fat diet. We show that mice deficient in these adhesion receptors are unable to respond to fasting by up-regulation of fatty acid oxidation. Normal mice, when fasted, exhibit reduced circulating neutrophil counts and increased ICAM-1 expression and neutrophil recruitment in liver. Mice lacking ICAM-1 or beta2 integrins fail to show these responses--instead they become hypoglycemic with steatotic livers. Fasting ICAM-1-deficient mice reduce insulin more slowly than wild-type mice. This produces fasting hyperinsulinemia that prevents activation of adenosine mono-phosphate (AMP)-activated protein kinase in muscles and liver, which results in decreased import of long chain fatty acids into mitochondria. Thus, we show a new role for immune cells and their adhesion receptors in regulating metabolic response to fasting.
Collapse
Affiliation(s)
- Aleksandar M Babic
- The CBR Institute for Biomedical Research, Boston, Massachussetts, USA
- Department of Pathology, Harvard Medical School, Boston, Massachusetts, USA
- Division of Clinical Pathology/Department of Pathology, Brigham and Women’s Hospital, Boston, Massachusetts, USA
| | - Hong-Wei Wang
- The CBR Institute for Biomedical Research, Boston, Massachussetts, USA
- Department of Pathology, Harvard Medical School, Boston, Massachusetts, USA
| | - Margaret J Lai
- The CBR Institute for Biomedical Research, Boston, Massachussetts, USA
| | - Thomas G Daniels
- Metabolic Diseases Physiology and Pharmacology, Millennium Pharmaceuticals, Cambridge, Massuchusetts, USA
| | - Thomas W Felbinger
- The CBR Institute for Biomedical Research, Boston, Massachussetts, USA
- Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA
| | - Peter C Burger
- The CBR Institute for Biomedical Research, Boston, Massachussetts, USA
- Department of Pathology, Harvard Medical School, Boston, Massachusetts, USA
| | - Alain Stricker-Krongrad
- Metabolic Diseases Physiology and Pharmacology, Millennium Pharmaceuticals, Cambridge, Massuchusetts, USA
| | - Denisa D Wagner
- The CBR Institute for Biomedical Research, Boston, Massachussetts, USA
- Department of Pathology, Harvard Medical School, Boston, Massachusetts, USA
- Address correspondence and reprint requests to Denisa D. Wagner, The CBR Institute for Biomedical Research, 800 Huntington Avenue, Boston, MA 02115. Phone: 617-278-3344; fax: 617-278-3368; e-mail:
| |
Collapse
|
2428
|
Zulet MA, Marti A, Parra MD, Martínez JA. Inflammation and conjugated linoleic acid: mechanisms of action and implications for human health. J Physiol Biochem 2006; 61:483-94. [PMID: 16440602 DOI: 10.1007/bf03168454] [Citation(s) in RCA: 43] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/22/2023]
Abstract
Data from a number of studies and trials have shown that different conjugated linoleic acids (CLA's) may produce beneficial effects on cancer, atherosclerosis, hypertension, diabetes and changes in body composition. Despite the increasing knowledge about CLA's implications on health, the mechanism of action of these fatty acids is not completely understood. Moreover, human studies indicate that some of these beneficial effects are considerably less evident than anticipated from mice studies, while the efficacy and safety of dietary supplements containing CLA have been questioned in some intervention trials. Recently, it has been suggested that the anti-carcinogenic and anti-atherosclerosis effects of CLA's stem from its anti-inflammatory properties. Because inflammatory responses are associated with the pathophysiology of many diseases, including obesity and the metabolic syndrome, the investigation in this area is of growing interest in recent years.
Collapse
Affiliation(s)
- M A Zulet
- Departamento de Fisiología y Nutrición, Facultad de Farmacia, Universidad de Navarra, Pamplona, Spain
| | | | | | | |
Collapse
|
2429
|
Abstract
Obesity is associated with increased macrophage infiltration of adipose tissue, and these macrophages may be an important component of the chronic inflammatory response playing a crucial role in the development of insulin resistance. This prompts the question as to how macrophages infiltrate obese adipose tissue. In this issue of the JCI, Weisberg et al. show the importance of C-C motif chemokine receptor 2 (CCR2) in macrophage recruitment to adipose tissue and the development of obesity and its complications.
Collapse
Affiliation(s)
- Jaap G Neels
- Department of Medicine, Division of Endocrinology and Metabolism, UCSD, La Jolla, California 92093-0673, USA
| | | |
Collapse
|
2430
|
Kim TH, Kim NS, Lim D, Lee KT, Oh JH, Park HS, Jang GW, Kim HY, Jeon M, Choi BH, Lee HY, Chung HY, Kim H. Generation and analysis of large-scale expressed sequence tags (ESTs) from a full-length enriched cDNA library of porcine backfat tissue. BMC Genomics 2006; 7:36. [PMID: 16504160 PMCID: PMC1444929 DOI: 10.1186/1471-2164-7-36] [Citation(s) in RCA: 27] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/27/2005] [Accepted: 02/27/2006] [Indexed: 11/13/2022] Open
Abstract
Background Genome research in farm animals will expand our basic knowledge of the genetic control of complex traits, and the results will be applied in the livestock industry to improve meat quality and productivity, as well as to reduce the incidence of disease. A combination of quantitative trait locus mapping and microarray analysis is a useful approach to reduce the overall effort needed to identify genes associated with quantitative traits of interest. Results We constructed a full-length enriched cDNA library from porcine backfat tissue. The estimated average size of the cDNA inserts was 1.7 kb, and the cDNA fullness ratio was 70%. In total, we deposited 16,110 high-quality sequences in the dbEST division of GenBank (accession numbers: DT319652-DT335761). For all the expressed sequence tags (ESTs), approximately 10.9 Mb of porcine sequence were generated with an average length of 674 bp per EST (range: 200–952 bp). Clustering and assembly of these ESTs resulted in a total of 5,008 unique sequences with 1,776 contigs (35.46%) and 3,232 singleton (65.54%) ESTs. From a total of 5,008 unique sequences, 3,154 (62.98%) were similar to other sequences, and 1,854 (37.02%) were identified as having no hit or low identity (<95%) and 60% coverage in The Institute for Genomic Research (TIGR) gene index of Sus scrofa. Gene ontology (GO) annotation of unique sequences showed that approximately 31.7, 32.3, and 30.8% were assigned molecular function, biological process, and cellular component GO terms, respectively. A total of 1,854 putative novel transcripts resulted after comparison and filtering with the TIGR SsGI; these included a large percentage of singletons (80.64%) and a small proportion of contigs (13.36%). Conclusion The sequence data generated in this study will provide valuable information for studying expression profiles using EST-based microarrays and assist in the condensation of current pig TCs into clusters representing longer stretches of cDNA sequences. The isolation of genes expressed in backfat tissue is the first step toward a better understanding of backfat tissue on a genomic basis.
Collapse
Affiliation(s)
- Tae-Hun Kim
- Division of Animal Genomics & Bioinformatics, National LivestockResearch Institute, Rural Development Administration, Omokchun-dong 564, Kwonsun-gu, Suwon, Korea
| | - Nam-Soon Kim
- Laboratory of Human Genomics, Genome Research Center, Korea Research Institute of Bioscience & Biotechnology, Daejeon, Korea
| | - Dajeong Lim
- School of Agricultural Biotechnology, Seoul National University San 56-1, Sillim-dong, Gwanak-gu, Seoul 151-742, Korea
| | - Kyung-Tai Lee
- Division of Animal Genomics & Bioinformatics, National LivestockResearch Institute, Rural Development Administration, Omokchun-dong 564, Kwonsun-gu, Suwon, Korea
| | - Jung-Hwa Oh
- Laboratory of Human Genomics, Genome Research Center, Korea Research Institute of Bioscience & Biotechnology, Daejeon, Korea
| | - Hye-Sook Park
- Division of Animal Genomics & Bioinformatics, National LivestockResearch Institute, Rural Development Administration, Omokchun-dong 564, Kwonsun-gu, Suwon, Korea
| | - Gil-Won Jang
- Division of Animal Genomics & Bioinformatics, National LivestockResearch Institute, Rural Development Administration, Omokchun-dong 564, Kwonsun-gu, Suwon, Korea
| | - Hyung-Yong Kim
- Division of Animal Genomics & Bioinformatics, National LivestockResearch Institute, Rural Development Administration, Omokchun-dong 564, Kwonsun-gu, Suwon, Korea
| | - Mina Jeon
- School of Agricultural Biotechnology, Seoul National University San 56-1, Sillim-dong, Gwanak-gu, Seoul 151-742, Korea
| | - Bong-Hwan Choi
- Division of Animal Genomics & Bioinformatics, National LivestockResearch Institute, Rural Development Administration, Omokchun-dong 564, Kwonsun-gu, Suwon, Korea
| | - Hae-Young Lee
- Division of Animal Genomics & Bioinformatics, National LivestockResearch Institute, Rural Development Administration, Omokchun-dong 564, Kwonsun-gu, Suwon, Korea
| | - HY Chung
- Division of Animal Genomics & Bioinformatics, National LivestockResearch Institute, Rural Development Administration, Omokchun-dong 564, Kwonsun-gu, Suwon, Korea
| | - Heebal Kim
- School of Agricultural Biotechnology, Seoul National University San 56-1, Sillim-dong, Gwanak-gu, Seoul 151-742, Korea
| |
Collapse
|
2431
|
Roche R, Hoareau L, Bes-Houtmann S, Gonthier MP, Laborde C, Baron JF, Haffaf Y, Cesari M, Festy F. Presence of the cannabinoid receptors, CB1 and CB2, in human omental and subcutaneous adipocytes. Histochem Cell Biol 2006; 126:177-87. [PMID: 16395612 DOI: 10.1007/s00418-005-0127-4] [Citation(s) in RCA: 112] [Impact Index Per Article: 6.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 12/01/2005] [Indexed: 02/06/2023]
Abstract
To investigate the expression of the endocannabinoid 1 and 2 receptors by human adipocyte cells of omental and subcutaneous fat tissue, as well as to determine whether these receptors are functional. The expression of CB1 and CB2 receptors on human adipocytes was analyzed by western blotting, immunohistology and immunocytology. We also investigated intracytoplasmic cyclic AMP level modulation following CB1 and CB2 receptor stimulation by an enzymatic immuno assay. All mature adipocytes, from visceral (epiploon) and subcutaneous fat tissue, express CB1 and CB2 on their plasma membranes. We also demonstrate in this study that adipocyte precursors (pre-adipocytes) express CB1 and CB2 on their plasma membranes and that both receptors are functional. Activation of CB1 increases intracytoplasmic cyclic AMP whilst CB2 activation leads to a cyclic AMP decrease. Here we demonstrate, for the first time, that adipocytes of human adipose tissue (mature adipocytes and pre-adipocytes) express functional plasma membrane CB1 and CB2 receptors. Their physiological role on the adipose tissue is not known. However, their major involvement in the physiology of other tissues leads us to suppose that they could play a significant role in the homeostasis of the energy balance and/or in the regulation of adipose tissue inflammation.
Collapse
Affiliation(s)
- Régis Roche
- LBGM, Laboratoire de Biochimie et de Génétique Moléculaire, Université de l'île de la Réunion, 15 avenue René Cassin, 97715 Saint Denis Messag Cedex, France
| | | | | | | | | | | | | | | | | |
Collapse
|
2432
|
Guijarro A, Laviano A, Meguid MM. Hypothalamic integration of immune function and metabolism. PROGRESS IN BRAIN RESEARCH 2006; 153:367-405. [PMID: 16876587 PMCID: PMC7119041 DOI: 10.1016/s0079-6123(06)53022-5] [Citation(s) in RCA: 57] [Impact Index Per Article: 3.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Indexed: 12/24/2022]
Abstract
The immune and neuroendocrine systems are closely involved in the regulation of metabolism at peripheral and central hypothalamic levels. In both physiological (meals) and pathological (infections, traumas and tumors) conditions immune cells are activated responding with the release of cytokines and other immune mediators (afferent signals). In the hypothalamus (central integration), cytokines influence metabolism by acting on nucleus involved in feeding and homeostasis regulation leading to the acute phase response (efferent signals) aimed to maintain the body integrity. Peripheral administration of cytokines, inoculation of tumor and induction of infection alter, by means of cytokine action, the normal pattern of food intake affecting meal size and meal number suggesting that cytokines acted differentially on specific hypothalamic neurons. The effect of cytokines-related cancer anorexia is also exerted peripherally. Increase plasma concentrations of insulin and free tryptophan and decrease gastric emptying and d-xylose absorption. In addition, in obesity an increase in interleukin (IL)-1 and IL-6 occurs in mesenteric fat tissue, which together with an increase in corticosterone, is associated with hyperglycemia, dyslipidemias and insulin resistance of obesity-related metabolic syndrome. These changes in circulating nutrients and hormones are sensed by hypothalamic neurons that influence food intake and metabolism. In anorectic tumor-bearing rats, we detected upregulation of IL-1beta and IL-1 receptor mRNA levels in the hypothalamus, a negative correlation between IL-1 concentration in cerebro-spinal fluid and food intake and high levels of hypothalamic serotonin, and these differences disappeared after tumor removal. Moreover, there is an interaction between serotonin and IL-1 in the development of cancer anorexia as well as an increase in hypothalamic dopamine and serotonin production. Immunohistochemical studies have shown a decrease in neuropeptide Y (NPY) and dopamine (DA) and an increase in serotonin concentration in tumor-bearing rats, in first- and second-order hypothalamic nuclei, while tumor resection reverted these changes and normalized food intake, suggesting negative regulation of NPY and DA systems by cytokines during anorexia, probably mediated by serotonin that appears to play a pivotal role in the regulation of food intake in cancer. Among the different forms of therapy, nutritional manipulation of diet in tumor-bearing state has been investigated. Supplementation of tumor bearing rats with omega-3 fatty acid vs. control diet delayed the appearance of tumor, reduced tumor-growth rate and volume, negated onset of anorexia, increased body weight, decreased cytokines production and increased expression of NPY and decreased alpha-melanocyte-stimulating hormone (alpha-MSH) in hypothalamic nuclei. These data suggest that omega-3 fatty acid suppressed pro-inflammatory cytokines production and improved food intake by normalizing hypothalamic food intake-related peptides and point to the possibility of a therapeutic use of these fatty acids. The sum of these data support the concept that immune cell-derived cytokines are closely related with the regulation of metabolism and have both central and peripheral actions, inducing anorexia via hypothalamic anorectic factors, including serotonin and dopamine, and inhibiting NPY leading to a reduction in food intake and body weight, emphasizing the interconnection of the immune and neuroendocrine systems in regulating metabolism during infectious process, cachexia and obesity.
Collapse
Affiliation(s)
- Ana Guijarro
- Surgical Metabolism and Nutrition Laboratory, Neuroscience Program, University Hospital, SUNY Upstate Medical University, 750 Adams St., Syracuse, NY 13210, USA
| | | | | |
Collapse
|
2433
|
Weisberg SP, Hunter D, Huber R, Lemieux J, Slaymaker S, Vaddi K, Charo I, Leibel RL, Ferrante AW. CCR2 modulates inflammatory and metabolic effects of high-fat feeding. J Clin Invest 2005; 116:115-24. [PMID: 16341265 PMCID: PMC1307559 DOI: 10.1172/jci24335] [Citation(s) in RCA: 1215] [Impact Index Per Article: 63.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/27/2004] [Accepted: 09/12/2005] [Indexed: 12/13/2022] Open
Abstract
The C-C motif chemokine receptor-2 (CCR2) regulates monocyte and macrophage recruitment and is necessary for macrophage-dependent inflammatory responses and the development of atherosclerosis. Although adipose tissue expression and circulating concentrations of CCL2 (also known as MCP1), a high-affinity ligand for CCR2, are elevated in obesity, the role of CCR2 in metabolic disorders, including insulin resistance, hepatic steatosis, and inflammation associated with obesity, has not been studied. To determine what role CCR2 plays in the development of metabolic phenotypes, we studied the effects of Ccr2 genotype on the development of obesity and its associated phenotypes. Genetic deficiency in Ccr2 reduced food intake and attenuated the development of obesity in mice fed a high-fat diet. In obese mice matched for adiposity, Ccr2 deficiency reduced macrophage content and the inflammatory profile of adipose tissue, increased adiponectin expression, ameliorated hepatic steatosis, and improved systemic glucose homeostasis and insulin sensitivity. In mice with established obesity, short-term treatment with a pharmacological antagonist of CCR2 lowered macrophage content of adipose tissue and improved insulin sensitivity without significantly altering body mass or improving hepatic steatosis. These data suggest that CCR2 influences the development of obesity and associated adipose tissue inflammation and systemic insulin resistance and plays a role in the maintenance of adipose tissue macrophages and insulin resistance once obesity and its metabolic consequences are established.
Collapse
Affiliation(s)
- Stuart P Weisberg
- Department of Medicine, Naomi Berrie Diabetes Center, Columbia University College of Physicians and Surgeons, New York, New York 10032, USA
| | | | | | | | | | | | | | | | | |
Collapse
|
2434
|
Chung1 S, Brown2 JM, Provo1 JN, Hopkins1 R, McIntosh1 MK. Conjugated linoleic acid promotes human adipocyte insulin resistance through NFkappaB-dependent cytokine production. J Biol Chem 2005; 280:38445-56. [PMID: 16155293 PMCID: PMC1289266 DOI: 10.1074/jbc.m508159200] [Citation(s) in RCA: 130] [Impact Index Per Article: 6.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/04/2023] Open
Abstract
We previously demonstrated that trans-10, cis-12 conjugated linoleic acid (CLA) reduced the triglyceride content of human adipocytes by activating mitogen-activated protein kinase kinase/extracellular signal-related kinase (MEK/ERK) signaling via interleukins (IL) 6 and 8. However, the upstream mechanism is unknown. Here we show that CLA increased (>or=6 h) the secretion of IL-6 and IL-8 in cultures containing both differentiated adipocytes and stromal vascular (SV) cells, non-differentiated SV cells, and adipose tissue explants. CLA isomer-specific induction of IL-6 and tumor necrosis factor-alpha was associated with the activation of nuclear factor kappaB (NFkappaB) as evidenced by 1) phosphorylation of IkappaBalpha, IkappaBalpha kinase, and NFkappaB p65, 2) IkappaBalpha degradation, and 3) nuclear translocation of NFkappaB. Pretreatment with selective NFkappaB inhibitors and the MEK/ERK inhibitor U0126 blocked CLA-mediated IL-6 gene expression. Trans-10, cis-12 CLA suppression of insulin-stimulated glucose uptake at 24 h was associated with decreased total and plasma membrane glucose transporter 4 proteins. Inhibition of NFkappaB activation or depletion of NFkappaB by RNA interference using small interfering NFkappaB p65 attenuated CLA suppression of glucose transporter 4 and peroxisome proliferator-activated receptor gamma proteins and glucose uptake. Collectively, these data demonstrate for the first time that trans-10, cis-12 CLA promotes NFkappaB activation and subsequent induction of IL-6, which are at least in part responsible for trans-10, cis-12 CLA-mediated suppression of peroxisome proliferator-activated receptor gamma target gene expression and insulin sensitivity in mature human adipocytes.
Collapse
Affiliation(s)
- Soonkyu Chung1
- From the Department of Nutrition, University of North Carolina at Greensboro, Greensboro, North Carolina 27402-6170 and the Department of Pathology and Comparative Medicine, Wake Forest School of Medicine, Winston Salem, North Carolina 27157
| | - J. Mark Brown2
- From the Department of Nutrition, University of North Carolina at Greensboro, Greensboro, North Carolina 27402-6170 and the Department of Pathology and Comparative Medicine, Wake Forest School of Medicine, Winston Salem, North Carolina 27157
| | - J. Nathan Provo1
- From the Department of Nutrition, University of North Carolina at Greensboro, Greensboro, North Carolina 27402-6170 and the Department of Pathology and Comparative Medicine, Wake Forest School of Medicine, Winston Salem, North Carolina 27157
| | - Robin Hopkins1
- From the Department of Nutrition, University of North Carolina at Greensboro, Greensboro, North Carolina 27402-6170 and the Department of Pathology and Comparative Medicine, Wake Forest School of Medicine, Winston Salem, North Carolina 27157
| | - Michael K. McIntosh1
- From the Department of Nutrition, University of North Carolina at Greensboro, Greensboro, North Carolina 27402-6170 and the Department of Pathology and Comparative Medicine, Wake Forest School of Medicine, Winston Salem, North Carolina 27157
| |
Collapse
|
2435
|
Ogawa S, Lozach J, Benner C, Pascual G, Tangirala RK, Westin S, Hoffmann A, Subramaniam S, David M, Rosenfeld MG, Glass CK. Molecular determinants of crosstalk between nuclear receptors and toll-like receptors. Cell 2005; 122:707-21. [PMID: 16143103 PMCID: PMC1430687 DOI: 10.1016/j.cell.2005.06.029] [Citation(s) in RCA: 496] [Impact Index Per Article: 26.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/05/2005] [Revised: 05/08/2005] [Accepted: 06/24/2005] [Indexed: 12/14/2022]
Abstract
Nuclear receptors (NRs) repress transcriptional responses to diverse signaling pathways as an essential aspect of their biological activities, but mechanisms determining the specificity and functional consequences of transrepression remain poorly understood. Here, we report signal- and gene-specific repression of transcriptional responses initiated by engagement of toll-like receptors (TLR) 3, 4, and 9 in macrophages. The glucocorticoid receptor (GR) represses a large set of functionally related inflammatory response genes by disrupting p65/interferon regulatory factor (IRF) complexes required for TLR4- or TLR9-dependent, but not TLR3-dependent, transcriptional activation. This mechanism requires signaling through MyD88 and enables the GR to differentially regulate pathogen-specific programs of gene expression. PPARgamma and LXRs repress overlapping transcriptional targets by p65/IRF3-independent mechanisms and cooperate with the GR to synergistically transrepress distinct subsets of TLR-responsive genes. These findings reveal combinatorial control of homeostasis and immune responses by nuclear receptors and suggest new approaches for treatment of inflammatory diseases.
Collapse
Affiliation(s)
- Sumito Ogawa
- Department of Cellular and Molecular Medicine, University of California, San Diego, 9500 Gilman Drive, La Jolla, California 92093, USA
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
2436
|
Maroof A, English NR, Bedford PA, Gabrilovich DI, Knight SC. Developing dendritic cells become 'lacy' cells packed with fat and glycogen. Immunology 2005; 115:473-83. [PMID: 16011516 PMCID: PMC1782181 DOI: 10.1111/j.1365-2567.2005.02181.x] [Citation(s) in RCA: 32] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/13/2022] Open
Abstract
On maturation, dendritic cells (DCs) become highly active cells equipped for antigen uptake, migration and clustering and activation of T cells. We therefore asked whether DCs acquire fat and glycogen stores as they mature. DCs were generated from mouse bone marrow stem cells by culturing with granulocyte-macrophage colony-stimulating factor (GM-CSF) for 7-8 days. Stimulation of the DCs with lipopolysaccharide (LPS) for the last 24 hr of culture, or exposure to 1-15 ng/ml of interleukin (IL)-4 during development, resulted in production of DCs not only with an increased ability to stimulate T cells but also with an increasingly lacy appearance on transmission electron microscopy, with multiple unstained areas in the cytoplasm. This changed morphology was associated with the presence of increasing amounts of fat and glycogen, identified by Sudan Black and periodic acid leukofushin/Schiff (PAS) staining, respectively. Lacy DCs up-regulated type 1 and type 2 scavenger receptors, providing possible mechanisms contributing to these changes. Lacy DCs were found occasionally amongst freshly isolated splenic and lymph node DCs. DCs can be isolated from human adipose tissue, and we tested whether lacy DCs acquiring fat and glycogen were present in mouse omentum. CD45+ cells migrating from the omentum expressed specific DC markers CD11c and 33D1, costimulatory molecules and major histocompatibility complex (MHC) class II, and most showed darkly staining fat inclusions. Thus, during development, DCs can acquire large amounts of fat and glycogen, accumulation of which is promoted by antigen exposure and modulated by the cytokine milieu and location, and which may act as a link between energy stores and immune function.
Collapse
Affiliation(s)
- Asher Maroof
- Antigen Presentation Research Group, Imperial College London, Harrow, UK
| | | | | | | | | |
Collapse
|
2437
|
Kahn R, Buse J, Ferrannini E, Stern M. The metabolic syndrome: time for a critical appraisal. Joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetologia 2005; 48:1684-99. [PMID: 16079964 DOI: 10.1007/s00125-005-1876-2] [Citation(s) in RCA: 278] [Impact Index Per Article: 14.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/17/2023]
Abstract
BACKGROUND The term 'metabolic syndrome' refers to a clustering of specific cardiovascular disease (CVD) risk factors whose underlying pathophysiology is thought to be related to insulin resistance. METHODS Since the term is widely used in research and clinical practice, we undertook an extensive review of the literature in relation to the syndrome's definition, underlying pathogenesis, association with cardiovascular disease and to the goals and impact of treatment. DISCUSSION While there is no question that certain CVD risk factors are prone to cluster, we found that the metabolic syndrome has been imprecisely defined, there is a lack of certainty regarding its pathogenesis, and there is considerable doubt regarding its value as a CVD risk marker. Our analysis indicates that too much critically important information is missing to warrant its designation as a 'syndrome'. CONCLUSION Until much-needed research is completed, clinicians should evaluate and treat all CVD risk factors without regard to whether a patient meets the criteria for diagnosis of the 'metabolic syndrome'.
Collapse
Affiliation(s)
- R Kahn
- American Diabetes Association, 1701 N. Beauregard Street, Alexandria, VA 22311, USA.
| | | | | | | |
Collapse
|
2438
|
Lee YH, Nair S, Rousseau E, Allison DB, Page GP, Tataranni PA, Bogardus C, Permana PA. Microarray profiling of isolated abdominal subcutaneous adipocytes from obese vs non-obese Pima Indians: increased expression of inflammation-related genes. Diabetologia 2005; 48:1776-83. [PMID: 16059715 PMCID: PMC1409820 DOI: 10.1007/s00125-005-1867-3] [Citation(s) in RCA: 161] [Impact Index Per Article: 8.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 12/10/2004] [Accepted: 04/28/2005] [Indexed: 10/25/2022]
Abstract
AIMS/HYPOTHESIS Obesity increases the risk of developing major diseases such as diabetes and cardiovascular disease. Adipose tissue, particularly adipocytes, may play a major role in the development of obesity and its comorbidities. The aim of this study was to characterise, in adipocytes from obese people, the most differentially expressed genes that might be relevant to the development of obesity. METHODS We carried out microarray gene profiling of isolated abdominal subcutaneous adipocytes from 20 non-obese (BMI 25+/-3 kg/m2) and 19 obese (BMI 55+/-8 kg/m2) non-diabetic Pima Indians using Affymetrix HG-U95 GeneChip arrays. After data analyses, we measured the transcript levels of selected genes based on their biological functions and chromosomal positions using quantitative real-time PCR. RESULTS The most differentially expressed genes in adipocytes of obese individuals consisted of 433 upregulated and 244 downregulated genes. Of these, 410 genes could be classified into 20 functional Gene Ontology categories. The analyses indicated that the inflammation/immune response category was over-represented, and that most inflammation-related genes were upregulated in adipocytes of obese subjects. Quantitative real-time PCR confirmed the transcriptional upregulation of representative inflammation-related genes (CCL2 and CCL3) encoding the chemokines monocyte chemoattractant protein-1 and macrophage inflammatory protein 1alpha. The differential expression levels of eight positional candidate genes, including inflammation-related THY1 and C1QTNF5, were also confirmed. These genes are located on chromosome 11q22-q24, a region with linkage to obesity in the Pima Indians. CONCLUSIONS/INTERPRETATION This study provides evidence supporting the active role of mature adipocytes in obesity-related inflammation. It also provides potential candidate genes for susceptibility to obesity.
Collapse
Affiliation(s)
- Y H Lee
- Obesity and Diabetes Clinical Research Section, Phoenix Epidemiology and Clinical Research Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Phoenix, AZ, USA
| | | | | | | | | | | | | | | |
Collapse
|
2439
|
Nair S, Lee YH, Rousseau E, Cam M, Tataranni PA, Baier LJ, Bogardus C, Permana PA. Increased expression of inflammation-related genes in cultured preadipocytes/stromal vascular cells from obese compared with non-obese Pima Indians. Diabetologia 2005; 48:1784-8. [PMID: 16034612 PMCID: PMC1409821 DOI: 10.1007/s00125-005-1868-2] [Citation(s) in RCA: 86] [Impact Index Per Article: 4.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 12/30/2004] [Accepted: 04/28/2005] [Indexed: 01/04/2023]
Abstract
AIMS/HYPOTHESIS The specific contributions made by the various cell types in adipose tissue to obesity, particularly obesity-related inflammation, need to be clarified. The aim of this study was to elucidate the potential role of adipocyte precursor cells (preadipocytes/stromal vascular cells [SVC]). METHODS We performed Affymetrix oligonucleotide microarray expression profiling of cultured abdominal subcutaneous preadipocytes/SVC isolated from the adipose tissue of 14 non-obese (BMI 25+/-4 kg/m2) and 14 obese (55+/-8 kg/m2) non-diabetic Pima Indian subjects. Quantitative real-time PCR (RT-PCR) was used to verify the differential expression of several genes in an independent group of subjects. RESULTS We identified 218 differentially expressed genes with p values less than 0.01. Microarray expression profiling revealed that the expression of inflammation-related genes was significantly upregulated in preadipocytes/SVC of obese individuals. Quantitative RT-PCR confirmed the upregulation of IL8, CTSS, ITGB2, HLA-DRA, CD53, PLA2G7 and MMP9 in preadipocytes/SVC of obese subjects. CONCLUSIONS/INTERPRETATION The upregulation of inflammation-related genes in preadipocytes/SVC of obese subjects may increase the recruitment of immune cells into adipose tissue and may also result in changes in the extracellular matrix (tissue remodelling) to accommodate adipose tissue expansion in obesity.
Collapse
Affiliation(s)
- S Nair
- Obesity and Diabetes Clinical Research Section, Phoenix Epidemiology and Clinical Research Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Phoenix, AZ 85016, USA.
| | | | | | | | | | | | | | | |
Collapse
|
2440
|
Soldatos G, Cooper ME, Jandeleit-Dahm KAM. Advanced-glycation end products in insulin-resistant states. Curr Hypertens Rep 2005; 7:96-102. [PMID: 15748532 DOI: 10.1007/s11906-005-0081-5] [Citation(s) in RCA: 24] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/21/2022]
Abstract
Insulin resistance is a central component of a number of clinical conditions, including the metabolic syndrome, diabetes, and hypertension. There is emerging evidence that the consequent hyperinsulinemia and visceral adiposity may be directly responsible for the excess cardiovascular morbidity and mortality seen in these conditions. Advanced-glycation end products, a chemically diverse group of compounds found in higher levels in insulin-resistant states, have also been shown to adversely affect endothelial function as well as activate numerous intracellular signaling pathways implicated in the atherosclerotic pathway. In this review, we summarize the factors thought to be important in both the initiation and exacerbation of the insulin-resistant state, and directly examine the potential role of advanced-glycation end products in this process.
Collapse
Affiliation(s)
- Georgia Soldatos
- Baker Heart Research Institute, Commercial Road, Melbourne 3181, Victoria, Australia
| | | | | |
Collapse
|
2441
|
Lamas O, Martínez JA, Marti A. Decreased splenic mRNA expression levels of TNF-alpha and IL-6 in diet-induced obese animals. J Physiol Biochem 2005; 60:279-83. [PMID: 15957247 DOI: 10.1007/bf03167074] [Citation(s) in RCA: 19] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/06/2023]
Abstract
Obesity could be considered as a systemic low-grade inflammatory condition affecting inflammation markers. Adipose tissue synthesizes cytokines whose degree of elevation may depend on the obesity status. Recently, new information is collected on the cross-talking between immune system and adipose tissue in obesity. We report hereby that tumor necrosis factor alpha (TNF-alpha) and interleukin 6 (IL-6) gene expression in spleen of diet-induced obese animals were markedly decreased (more than 50%) as a consequence of the high fat feeding during five weeks. Interestingly, a very significant negative correlation was found between splenic TNF-alpha mRNA levels and total fat pads (r = -0.806, p = 0.000). These findings support the hypothesis that TNF-alpha gene expression may follow different trends in obese animals adipocytes and splenocytes.
Collapse
Affiliation(s)
- O Lamas
- Department of Physiology and Nutrition, University of Navarra, C/ Irunlarrea, 1, 31008, Pamplona, Spain
| | | | | |
Collapse
|
2442
|
Abstract
Over the last decade, an abundance of evidence has emerged demonstrating a close link between metabolism and immunity. It is now clear that obesity is associated with a state of chronic low-level inflammation. In this article, we discuss the molecular and cellular underpinnings of obesity-induced inflammation and the signaling pathways at the intersection of metabolism and inflammation that contribute to diabetes. We also consider mechanisms through which the inflammatory response may be initiated and discuss the reasons for the inflammatory response in obesity. We put forth for consideration some hypotheses regarding important unanswered questions in the field and suggest a model for the integration of inflammatory and metabolic pathways in metabolic disease.
Collapse
Affiliation(s)
- Kathryn E Wellen
- Department of Genetics & Complex Diseases, Harvard School of Public Health, Boston, Massachusetts 02115, USA
| | | |
Collapse
|
2443
|
Abstract
Over the last decade, an abundance of evidence has emerged demonstrating a close link between metabolism and immunity. It is now clear that obesity is associated with a state of chronic low-level inflammation. In this article, we discuss the molecular and cellular underpinnings of obesity-induced inflammation and the signaling pathways at the intersection of metabolism and inflammation that contribute to diabetes. We also consider mechanisms through which the inflammatory response may be initiated and discuss the reasons for the inflammatory response in obesity. We put forth for consideration some hypotheses regarding important unanswered questions in the field and suggest a model for the integration of inflammatory and metabolic pathways in metabolic disease.
Collapse
Affiliation(s)
- Kathryn E Wellen
- Department of Genetics & Complex Diseases, Harvard School of Public Health, Boston, Massachusetts 02115, USA
| | | |
Collapse
|
2444
|
Abstract
Over the last decade, an abundance of evidence has emerged demonstrating a close link between metabolism and immunity. It is now clear that obesity is associated with a state of chronic low-level inflammation. In this article, we discuss the molecular and cellular underpinnings of obesity-induced inflammation and the signaling pathways at the intersection of metabolism and inflammation that contribute to diabetes. We also consider mechanisms through which the inflammatory response may be initiated and discuss the reasons for the inflammatory response in obesity. We put forth for consideration some hypotheses regarding important unanswered questions in the field and suggest a model for the integration of inflammatory and metabolic pathways in metabolic disease.
Collapse
Affiliation(s)
- Kathryn E Wellen
- Department of Genetics & Complex Diseases, Harvard School of Public Health, Boston, Massachusetts 02115, USA
| | | |
Collapse
|
2445
|
Affiliation(s)
- A Schäffler
- Department of Internal Medicine I, University of Regensburg, D-93042 Regensburg, Germany.
| | | |
Collapse
|
2446
|
Abstract
Subclinical, low-grade systemic inflammation has been observed in patients with type 2 diabetes and in those at increased risk of the disease. This may be more than an epiphenomenon. Alleles of genes encoding immune/inflammatory mediators are associated with the disease, and the two major environmental factors the contribute to the risk of type 2 diabetes-diet and physical activity-have a direct impact on levels of systemic immune mediators. In animal models, targeting of immune genes enhanced or suppressed the development of obesity or diabetes. Obesity is associated with the infiltration and proinflammatory activity of macrophages in adipose tissue, and immune mediators may be important regulators of insulin resistance, mitochondrial function, ectopic lipid storage and beta cell dysfunction or death. Intervention studies targeting these pathways would help to determine the contribution of an activated innate immune system to the development of type 2 diabetes.
Collapse
Affiliation(s)
- H Kolb
- German Diabetes Center, Leibniz-Institute at the University of Düsseldorf, Düsseldorf, Germany.
| | | |
Collapse
|
2447
|
Kimura H, Kimura M, Westra WH, Rose NR, Caturegli P. Increased thyroidal fat and goitrous hypothyroidism induced by interferon-gamma. Int J Exp Pathol 2005; 86:97-106. [PMID: 15810981 PMCID: PMC2517408 DOI: 10.1111/j.0959-9673.2005.00418.x] [Citation(s) in RCA: 16] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/10/2004] [Accepted: 11/05/2004] [Indexed: 11/29/2022] Open
Abstract
Summary Hashimoto's thyroiditis is associated with a diffuse lymphocytic infiltration of the stroma and a production of several cytokines, such as interferon-gamma (IFN-gamma). We previously reported that transgenic mice expressing IFN-gamma under the control of the thyroglobulin promoter develop primary hypothyroidism. In order to determine the long-term changes induced by IFN-gamma in the thyroid gland, we analysed cross-sectionally 202 mice (96 transgenic mice and 106 controls) of 0-650 days of age. Multiple linear regression analysis showed that, after adjusting for age and sex, thyr-IFN-gamma transgenic mice were 14% (3 g) smaller (P < 0.0001) and had a 5- to 6-fold bigger thyroid (P < 0.0001) than wild-type littermates. Transgenic thyroids showed striking histopathological changes in follicles, thyrocytes and stroma. Follicles were enlarged, irregular and were lined by thickened, granular and oxyphilic thyrocytes. The stroma contained a moderate and diffuse mononuclear infiltrate--mainly composed of macrophages--and, interestingly, a clear increase in the content of fat. These findings indicate that, in addition to hypothyroidism, chronic exposure of the thyroid to IFN-gamma leads also to macrophage infiltration and subsequent adipocyte expansion, suggesting a link between inflammation and fat accumulation.
Collapse
Affiliation(s)
- Hiroaki Kimura
- Department of Pathology, The Johns Hopkins Medical Institutions, Baltimore, MD, USA
| | | | | | | | | |
Collapse
|
2448
|
Bedoui S, Velkoska E, Bozinovski S, Jones JE, Anderson GP, Morris MJ. Unaltered TNF-alpha production by macrophages and monocytes in diet-induced obesity in the rat. JOURNAL OF INFLAMMATION-LONDON 2005; 2:2. [PMID: 15813957 PMCID: PMC1079929 DOI: 10.1186/1476-9255-2-2] [Citation(s) in RCA: 28] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 12/16/2004] [Accepted: 03/21/2005] [Indexed: 03/04/2023]
Abstract
Background Recent findings have established an association between obesity and immune dysfunction. However, most of the studies investigating the effects of obesity on immune function have been carried out in genetically obese rodent models. Since human obesity is mostly due to intake of a high fat diet and decreased energy expenditure, we asked whether immunological defects also occur in diet-induced obesity. Specifically, we focused on the function of monocytes and macrophages, as these cells are thought to be involved in the low-grade inflammation present in obesity. Methods Male Sprague-Dawley rats were fed a high-fat or a standard chow diet for either 2 or 10 weeks. At the end of the intervention period animals were anaesthetised, blood collected for determination of plasma mediator concentrations and lipopolysaccharide (LPS) stimulated production of TNF-α by monocytes. LPS stimulated production of TNF-α in alveolar macrophages was also determined. Results High-fat feeding for either 2 or 10 weeks resulted in significant increases in fat mass and serum leptin. Although increased serum leptin has previously been linked to modulation of innate immunity, we found no significant difference in the LPS stimulated production of TNF-α by either blood monocytes or alveolar macrophages between the dietary groups. Furthermore, we failed to find a significant increase in circulating TNF-α concentrations in obese animals, as reported for genetically obese animals. Conclusion Our data suggest that defects in innate immune function observed in genetically obese animals are not mimicked by dietary obesity, and may more likely reflect the gross abnormality in leptin function of these models. Further work is required delineate the effects of dietary obesity on inflammatory state and immune function.
Collapse
Affiliation(s)
- Sammy Bedoui
- Department of Pharmacology, The University of Melbourne, Melbourne, 3010, Australia
| | - Elena Velkoska
- Department of Pharmacology, The University of Melbourne, Melbourne, 3010, Australia
| | - Steve Bozinovski
- Cooperative Research Centre for Chronic Inflammatory Diseases, The University of Melbourne, Melbourne, 3010, Australia
| | - Jessica E Jones
- Cooperative Research Centre for Chronic Inflammatory Diseases, The University of Melbourne, Melbourne, 3010, Australia
| | - Gary P Anderson
- Department of Pharmacology, The University of Melbourne, Melbourne, 3010, Australia
- Department of Medicine, The University of Melbourne, Melbourne, 3010, Australia
- Cooperative Research Centre for Chronic Inflammatory Diseases, The University of Melbourne, Melbourne, 3010, Australia
| | - Margaret J Morris
- Department of Pharmacology, The University of Melbourne, Melbourne, 3010, Australia
| |
Collapse
|
2449
|
Poitou C, Viguerie N, Cancello R, De Matteis R, Cinti S, Stich V, Coussieu C, Gauthier E, Courtine M, Zucker JD, Barsh GS, Saris W, Bruneval P, Basdevant A, Langin D, Clément K. Serum amyloid A: production by human white adipocyte and regulation by obesity and nutrition. Diabetologia 2005; 48:519-28. [PMID: 15729583 DOI: 10.1007/s00125-004-1654-6] [Citation(s) in RCA: 132] [Impact Index Per Article: 6.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/19/2004] [Accepted: 10/31/2004] [Indexed: 12/18/2022]
Abstract
AIMS/HYPOTHESIS The acute-phase proteins, serum amyloid As (SAA), are precursors of amyloid A, involved in the pathogenesis of AA amyloidosis. This work started with the characterisation of systemic AA amyloidosis concurrent with SAA overexpression in the subcutaneous white adipose tissue (sWAT) of an obese patient with a leptin receptor deficiency. In the present study a series of histopathological, cellular and gene expression studies was performed to assess the importance of SAA in common obesity and its possible production by mature adipocytes. MATERIALS AND METHODS Gene expression profiling was performed in the sWAT of two extremely obese patients with a leptin receptor deficiency. Levels of the mRNAs of the different SAA isoforms were quantified in sWAT cellular fractions from lean subjects and from obese subjects before and after a very-low-calorie diet. These values were subsequently compared with serum levels of SAA in these individuals. In addition, histopathological analyses of sWAT were performed in lean and obese subjects. RESULTS In sWAT, the expression of SAA is more than 20-fold higher in mature adipocytes than in the cells of the stroma vascular fraction (p<0.01). Levels of SAA mRNA expression and circulating levels of the protein are sixfold (p<0.001) and 3.5-fold (p<0.01) higher in obese subjects than in lean subjects, respectively. In lean subjects, 5% of adipocytes are immunoreactive for SAA, whereas the corresponding value is greater than 20% in obese subjects. Caloric restriction results in decreases of 45-75% in levels of the transcripts for the SAA isoforms and in circulating levels of the protein. CONCLUSIONS/INTERPRETATION The results of the present study indicate that SAA is expressed by sWAT, and its production at this site is regulated by nutritional status. If amyloidosis is seen in the context of obesity, it is possible that production of SAA by adipocytes could be a contributory factor.
Collapse
Affiliation(s)
- C Poitou
- Department of Nutrition and Biochemistry, French Institute of Health and Medical Research Avenir, EA 3502, Paris VI University, Hôtel-Dieu Hospital, Paris, France
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
2450
|
Abstract
Obesity, in particular visceral obesity, has strong associations with cardiovascular disease and is related to many factors that are constituents of the metabolic syndrome. Increasing evidence suggests that features of the metabolic syndrome, including visceral obesity, are associated with a low-grade inflammatory state. Indeed, visceral fat is a source of several molecules, such as leptin, adiponectin, tumor necrosis factor-alpha, and interleukin 6, that are collectively called adipokines. All of them may induce a proinflammatory state and oxidative damage, leading to initiation and progression of atherosclerosis. Reduced-energy diets might represent an effective and healthful approach for long-term weight loss in patients with metabolic syndrome by reducing the underlying inflammatory condition.
Collapse
Affiliation(s)
- Patrizia Ferroni
- Department of Experimental Medicine & Pathology, University of Rome, Italy
| | | | | | | |
Collapse
|